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BENJAMIN ALEXANDER HUGHES. Mechanisms of Subtype-Specific Inhibition 
of N-methyl-D-aspartate Receptors by Ethanol. (Under the direction of JOHN J. 
WOODWARD). 
Alcoholism is a debilitating and costly disease with rates of prevalence 
totaling nearly 6% worldwide. Treating this disease has proven expensive and in 
many cases ineffective due in large part to significant gaps in our knowledge of 
the molecular determinants that drive the pathogenesis of the disorder. Recently, 
the N-methyl-D-aspartate (NMDA) receptor has emerged as a candidate site for 
the primary inhibitory actions of ethanol on nervous system function. This 
receptor is an ion channel highly expressed in the nervous system that is 
activated by the excitatory neurotransmitter glutamate and has been implicated in 
the induction of a number of cellular phenomena including the molecular 
underpinnings of learning and memory. Understanding how ethanol affects the 
function of this channel both acutely and chronically is crucial to understanding 
the manifestation and progression of alcohol use disorders. By employing site-
directed mutagenesis and patch-clamp electrophysiology with recombinant cell-
expression of mutant and wild type NMDA receptor subunit cDNAs, my research 
has identified a number of novel interacting sites of ethanol with the NMDA 
receptor complex. Additionally, this work has highlighted essential differences in 




subtypes, GluN2A- and GluN2B-containing in particular. Furthermore, by 
exploiting the phenomenon of bioluminescence resonance energy transfer 
(BRET) my work has also demonstrated that GluN2A- and GluN2B-containing 
NMDA receptor subtypes will co-assemble into novel receptor complexes. 
Further teasing the differential activity of ethanol on these NMDA receptor 
subtypes could lead not only to the development of novel and effective 
therapeutics for alcohol use disorders, but as well engender a better 





Chapter I. Background and Significance 
I.1 Alcohol and the Human Condition 
Alcohol enjoys an intimate relationship with nearly every human 
population on the planet and has in many ways shaped the trajectory of our 
collective development. Indeed, archaeological evidence suggests that the 
emergence of agrarian societies nearly 10,000 years ago (Johnson and Earle, 
2000) may have been in part motivated by the desire to produce ethanol-
containing beverages. Discovered by the molecular archaeologist Dr. Patrick 
McGovern amongst a number of pottery jars in a Neolithic North China village, 
the oldest example of a fermented beverage dates to nearly 9,000 years in age. 
Thanks to the efforts of an intrepid group of brewers at Dogfish Head Brewing 
Company (Milton, Delaware), this concoction is actually commercially available 
today. More contemporary examples of alcohol-driven social paradigm shifts 
abound as well, including the first demonstration by a nascent U.S. government 
that it could enact and enforce its own laws; evidenced by the suppression of 
violent protests in response to an unpopular whiskey tax, colloquially known as 
the Whiskey Rebellion of 1791.  
As a rule, though, immoderate indulgence often begets misfortune, and 
alcohol use is no exception. Current estimates indicate that alcohol-related 
deaths constitute nearly 6% of all fatalities worldwide, with many indicators 




prescient example of the more insidious nature of alcohol consumption occurred 
on the night of September 10th, 1897, when a heavily intoxicated London taxi 
driver named George Smith drove his cab into the side of a building, becoming 
the first known arrestee for operating a motor vehicle while inebriated 
(History.com, 2009). This infamous arrest has since faded from the public 
consciousness, though it heralded an enduring pattern of behavior that has 
resulted in the death or disability of hundreds of thousands of people in the 
United States alone. Harsh penalties including significant jail sentences and 
suspension of driving privileges have helped to curb the incidence of this 
phenomenon, but the behavior nevertheless persists with recent statistics pinning 
alcohol-related traffic fatalities at upwards of 10,000 annually (U.S. Department 
of Transportation, 2014). Drunk driving is emblematic of the profound effect 
alcohol intoxication has on an individual’s capacity to appropriately weigh risk 
versus reward, and is perhaps the most potent reminder of the cost of alcohol 
over-indulgence. Even if one opts not to drive intoxicated, though, excessive 
alcohol consumption still elicits a number of pathological neurobiological and 
peripheral adaptations that, while far less apparent than a car accident, can be 
equally as debilitating for the imbiber. 
In the coming sections, the body of literature probing the mechanisms of 
alcohol intoxication and abuse, from the earliest hypotheses on the molecular 
actions of ethanol to current models of circuit level adaptive changes that drive 




knowledge my work has sought to fill. Implicit in this review, though, will be a 
discussion of the novel molecular mechanisms of neuronal function discovered a 
fortiori in the pursuit of understanding the ever-prevalent scourge of alcoholism, 
revealing an existential duality often overlooked by the general public and 
researchers alike; that the uglier, pathological aspects of human behavior 
nevertheless offer a great deal of insight into the intrinsic nature of our nature. 
I.2 Early Indications of Ethanol Action: Inhibition of Excitation 
 As discussed, the nature of ethanol’s relationship with humanity is 
multifaceted, and indeed it is perhaps unsurprising that a functional gestalt for 
ethanol action on the central nervous system has proven equally elusive. The 
accumulation of motor impairment and other sedative-hypnotic behaviors 
observed with increasingly higher doses of alcohol led many to initially infer that 
alcohol primarily impaired the efficient transduction of excitatory 
neurotransmission (Wallgren and Barry, 1970). Though not necessarily a faulty 
assumption, this hypothesis lacked an adequately descriptive mechanism for 
ethanol-induced inhibition of excitation, leading researchers to probe the intrinsic 
processes governing neuronal excitability. Among these early reports it was 
observed that in the squid giant axon, 2-3% solutions of ethanol reliably inhibited 
action potentials. The doses employed by these studies (in the 320-480 mM 
range), however, are far above the lethal limit of mammals, casting doubt on their 
physiological relevance (Armstrong & Binstock, 1964; Moore, Ulbricht, & Takata, 




of cation transport across the cell membrane, the elemental basis of action 
potentials, thereby blunting neuronal firing and reducing excitability. Indeed, 
experiments initially seemed to confirm that alcohol appeared to inhibit the 
efficiency of sodium/potassium exchange by the Na+/K+ ATPase both acutely and 
chronically (Israel & Salazar, 1967; Carmichael & Israel, 1975). While an 
attractive mechanism of action, this hypothesis would ultimately fall out of favor 
as further experiments demonstrated an apparent cell-type specificity for the 
actions of ethanol, thus excluding such a generalized feature of neurons as a 
primary mode of alcohol action (Wayner, Ono, & Nolley, 1975).  
Incidentally, later efforts offered experimental evidence showing increased 
fluidity of plasma membranes following treatment with either anesthetics or 
ethanol suggesting a possible cause of blunted excitation (Chin & Goldstein, 
1977; Goldstein, Chin, & Lyon, 1982). This work was largely an extension of the 
Meyer and Overton theory of anesthesia, which posits that volatile anesthetics 
elicit their effects by disrupting the plasma membrane. This theory was derived 
from observations showing a linear correlation between the lipid solubility of an 
agent and its potency as an anesthetic. This theory, and by extension the 
membrane-fluidity hypothesis of ethanol action, was called into question by 
experiments demonstrating that the activity of lipid-free, non-membrane bound 
soluble proteins such as luciferase exhibited the same Meyer-Overton sensitivity 
to anesthetics (Franks & Lieb, 1984). These observations demonstrated that 




membrane dynamics alone, and further implied that proteins may harbor 
significant hydrophobic pockets that could accommodate anesthetic agents of 
various sizes. These findings, driven by the desire to understand the 
mechanisms of drug action, ultimately revealed an essential feature of protein 
structure that guides drug discovery to this day, and further underscores the 
reciprocal relationship between human pathology and scientific insight.   
 The inability of these proposed generalized features of alcohol action to 
sufficiently incorporate the diverse physiological effects of ethanol at behaviorally 
relevant doses implied that specific neuronal substrates must mediate 
intoxication. Phenomenologically, in brain homogenates, ethanol was 
consistently observed to elicit strong increases in concentration of the inhibitory 
neurotransmitter GABA that is primarily responsible for mediating inhibition in 
mammalian neurons. Subsequent radio-ligand binding studies observed that 
alcohol increased the binding of tritiated agonists to low-affinity GABA receptor 
sites, lending credence to this hypothesis (Hakkinen & Kulonen, 1959; Ticku, 
Burch, & Davis, 1983). While encouraging, these results could not reconcile 
observations intimating a direct effect of ethanol on processes mediating 
excitatory currents (Nicoll, 1972). Progress in resolving these substrates thus 
stalled, as the tools available to discriminate the myriad ion currents underlying 
excitatory neuronal activity remained coarse at best. With the development of 
high-affinity, high-potency agonists and antagonists, though, the means to isolate 




however, work probing them as sites of alcohol action progressed slowly, as 
results from emerging reports made apparent that the receptors underlying 
excitatory, largely glutamatergic, neurotransmission were heterogeneous and 
exhibited highly idiosyncratic behavior that differentially participated in functional 
roles well beyond simple signal propagation. Indeed, the initial studies describing 
these myriad receptor populations added further complexity to a model of 
nervous system function that was itself nascent and incomplete. 
I.3 Discrimination of Post-Synaptic Excitatory Receptor Populations  
The earliest descriptions of the nervous system by Claudius Galen posited 
that the brain was the seat of nervous system function, sending hollow 
emanations to terminal points of action on muscle groups or elsewhere, and 
seemed to agree with the anatomical prominence of these structures amongst 
increasingly intelligent animals. The question of what transduced central nervous 
or sensory signals via these fibrils remained unknown, and, in lieu of better 
hypotheses, his assertion that they ferried spirits persisted well through the era of 
Descartes. Otto Dieters, a German anatomist working in the mid-nineteenth 
century, is credited with establishing the reticular hypothesis of 
neurotransmission, in which he asserted the nervous system was fully connected 
and uninterrupted, sending electrical signals to their targets nigh instantaneously 
through reticular branches (now known as axons). Among his staunchest 
supporters was Camillo Golgi, who discovered a process by which neurons could 




contemporary of Golgi, Santiago Ramon y Cajal, used this very process, dubbed 
Golgi staining, to eventually visualize distinct gaps between neurons, refuting 
Golgi’s firmly held belief in the reticular hypothesis.  
The question of what purpose these gaps served, however, remained 
open, though many, including John Langley, a 20th century pharmacologist, 
inferred they formed some sort of chemical messaging system. Via the concerted 
efforts of John Langley, Otto Loewi, and others in describing the role of 
acetylcholine, an excitatory neurotransmitter, in signal transmission at the 
neuromuscular junction provided the first tangible evidence that signal 
transduction was likely receptor mediated. This key insight provided a framework 
for understanding the essential function of the central nervous system. While 
ligand/receptor dynamics are today understood to be the foundational basis of 
inter-neuronal communication, conclusive evidence of this paradigm did not 
emerge until 1952, when Alan Hodgkin and Andrew Huxley developed the 
voltage clamp method, widely considered a quantum leap in the study of cell to 
cell communication and for which they shared the Nobel Prize in 1963.  
This method rests on the electronic principle of voltage, which essentially 
describes the “potential” of electrons, or in this case aqueously dissolved 
charged ions, to move across a resistor, specifically the cell membrane: the 
actual flow of electrons across a resistor is current. At its most basic, then, the 
setup consists of two electrodes, one placed extracellularly and the other 




outside the cell, determine the membrane’s potential difference. The intracellular 
electrode then injects current to establish and maintain an experimenter-defined 
voltage across the membrane. When a stimulus is applied that activates ion 
channels within the membrane, for example bath-application of an ion channel's 
cognate agonist, the amount of current the intracellular electrode must inject to 
proportionally offset the stimulus-induced change in voltage allows the 
experimenter to determine functional characteristics of these channels such as 
what types of ions these channels flux and how many ions they can pass (i.e. – 
current). Furthermore, this system allows experimenters to pharmacologically 
define and isolate what sort of ion channels underlie specific changes in 
membrane potential in an otherwise diverse cellular milieu of receptors. 
Refinements to this technique by Erwin Neher and Bert Sakmann during the 
1970’s and 80’s, specifically introducing the concept of establishing a giga-Ohm 
seal between the recording electrode and the cell membrane, have subsequently 
allowed researchers to measure changes in current or voltage at the population, 






The electrophysiological techniques described above gave researchers 
the tight experimental control and fine temporal precision necessary to 
understand the elemental features of neurotransmission, and were essential to 
early reports that established both the ionic basis of neuron excitability and the 
receptor/channel-dependency of neural responses outlined by Langley, Loewi, 
and others. As it was largely unknown what types of receptors governed inter-
neuronal signaling, much less their number and functional properties, the 
elucidation of these represented fertile ground for the application of this nascent 
experimental design. In tandem with continuing refinements to 
electrophysiological procedures, the development of potent, selective 
pharmacological agents proved invaluable in first discriminating the substrates of 
these neurotransmitters and their respective roles in neural activity. Among these 
early electrophysiological experiments were descriptions of amino acids evoking 
both neuronal excitation (L-glutamate) and inhibition (GABA) that seemed to 
reveal a binary mode of neuronal activity (Curtis & Watkins, 1960; Curtis & 
Watkins, 1963). By showing that differential activity of excitatory or inhibitory 
inputs on specific motor neurons in the squid could elicit either simple reflexes or 
complex motivated responses, Kupfermann and Kandel (1969) showed that this 
binary model of neurotransmission permitted the large scale computational 
Figure I.1: Schematic depicts a voltage-clamp electrophysiological setup. The amount of 
current required to offset the voltage potential difference between the reference electrode (a) 
and the recording electrode (b) by the amplifier (c) in response to a stimulus, in this case 
agonist application, is read by the experimenter as current conducted by the receptor 




processing necessary to produce behavior. Additionally, the discovery of the mu-
opioid receptor, and later additional peptidergic neurotransmitters such as 
endorphin and substance P, further amended this model by incorporating the 
concept of neuromodulation, in which certain classes of neurotransmitters do not 
themselves directly elicit neuronal activity but instead tune the degree of 
excitation or inhibition, thereby vastly increasing the computing power of 
neuronal communication (Pert & Snyder, 1973; Knoishi & Otsuka, 1974). Owing 
to the initial reports of robust glutamate-induced neuronal excitation, though, a 
considerable premium was placed on the characterization of potent and selective 
analogues of glutamate, and thus was it demonstrated that multiple receptor 
subtypes with diverse signaling properties likely mediate excitatory responses 
elicited by glutamate, weaving further nuance into the existing models of 









Interestingly enough, initial development of these glutamatergic analogues 
partly arose from the search for novel anti-parasitics and insecticides that were 
subsequently observed to elicit robust effects on neuronal excitation, echoing the 
guiding theme that pathological states drive our understanding of basic cellular 
function (Shinozaki & Konishi, 1970). Kainic acid was among these first 
analogues described and produced significant excitation with application, albeit 
to a much more modest degree than L-glutamate (Johnston, Curtis, Davies, & 
McCulloch, 1974). Structurally similar to kainic acid, quisqualate was similarly 
shown to elicit excitation, though considerably stronger than kainate and nearly 
two orders of magnitude more potent than L-glutamate (Shinozaki & Shibuya, 
Figure I.2: Summation of differential excitatory and 
inhibitory impulses on a postsynaptic neuron dictates 
whether the neuron will fire an action potential. 
Excitatory synapses exhibit a distinctive presynaptic 
bouton/postsynaptic spine morphology, while inhibitory 
terminals impinge directly on the dendritic shaft or cell 
body (a). Blown up view of an archetypal excitatory 
synapse demonstrates how influx of calcium subsequent 
to arrival of an action potential at the axon terminal 
bouton triggers neurotransmitter release into the 
synapse, activating postsynaptic receptors that permit 
entry of charged ions, ultimately further propagating the 




1974; Biscoe et al., 1975). When rank-ordered by potency, these analogues 
appeared to demonstrate two distinct receptor populations; these quisqualate- 
and kainate-sensitive receptors are now referred to as AMPA and Kainate 
respectively. 
While kainate and quisqualate were shown to reliably evoke excitation, 
additional contemporaneous reports showed that structurally distinct aspartate 
analogues also elicited excitatory responses, albeit with slower kinetics, implying 
that a class of glutamatergic receptor existed apart from AMPA and Kainate 
receptors (Johnston, Curtis, Davies, & McCulloch, 1974; Biscoe et al., 1976). 
Discovery of the robust antagonistic properties of DAA, and later DL-AP5 with 
much higher potency, on these kainate-/quisqualate-insensitive currents finally 
resolved this orphan receptor, and it was subsequently named the N-methyl-D-
aspartate receptor after its most potent aspartate-derived agonist (McLennan & 
Hall, 1978; Collingridge & Davies, 1979; Davies & Watkins, 1979; Evans et al., 
1979; Davies & Watkins, 1982).  
I.4 Unique Characteristics of the N-methyl-D-aspartate Receptor 
Experiments immediately revealed that this novel receptor population 
exhibited a host of unique features distinct from AMPA- and kainate-sensitive 
receptor types. Chief among the first reports describing NMDA-sensitive 
receptors was a consistently noted innate sensitivity to magnesium not seen with 
kainate- and AMPA-type receptors as well as voltage-dependent regenerative 




(Ault et al., 1980; MacDonald, Porietis, & Wojtowicz, 1982). These observations 
have since been revealed to be governed by the same mechanism. Under 
normal hyperpolarized neuronally quiescent conditions extracellular magnesium 
infiltrates and blocks the central pore of the NMDA receptor. Upon increasing 
depolarization from AMPA/Kainate receptor activity, magnesium block of 
NMDARs is proportionally diminished, and with sufficient depolarization allows 
ion flux through the channel. Thus, the voltage sensitivity of the NMDA-receptor 
is a consequence of voltage-dependent magnesium blockade and not due to a 
receptor-intrinsic physical voltage gate in contrast to axonal sodium channels 
(Nowak et al., 1984; Mayer, Westbrook, & Guthrie, 1984). Depolarization-induced 
relief of NMDAR magnesium blockade is consistent with initial studies showing 
that NMDA application resulted in a slow accumulation of excitation (Johnston et 
al., 1974), though the significance of this feature would not be fully appreciated 
until later reports demonstrated that NMDA receptors are essential elements in 
the molecular mechanisms of learning and memory (discussed in greater detail in 
Section I.8).  
While the innate Mg2+ sensitivity of the NMDAR was described, at least 
phenomenologically, soon after the discovery of the receptor itself, the underlying 
mechanism(s) that governed this feature remained unknown. Fortuitously, 
emerging reports on AMPA receptor function would guide researchers to an 
answer. Experiments conducted by the Seeburg laboratory in 1991 showed that 




that resulted in substitution of the coded glutamine (Q) codon at a critical 
channel-forming segment into a charged arginine (R) in certain AMPA subunits, 
resulting in a number of profound changes in channel activity (Sommer et al., 
1991). Among these functional changes observed with mutation of GluA2 Q607 
to an arginine was a significant attenuation of the calcium permeability of the 
receptor (Puchalski et al., 1994). The constitutive prominence of GluA2-
containing AMPARs in the synapse under basal neurotransmission has 
subsequently been suggested to be a neuroprotective adaptation to guard 
against calcium-induced excitotoxicity. Specific inclusion of GluA2-lacking 
AMPARs after induction of LTP (discussed later in Section I.8) may represent a 
positive feedback loop to maintain calcium-dependent functional adaptations 
(Kim et al., 2001).  
The presence of a similarly re-entrant pore-defining region in the NMDA 
receptor, coupled with reports of the high intrinsic calcium permeability of 
NMDARs, prompted researchers to speculate a central role for this region in 
governing ion selectivity. While the native cognate residue in NMDARs (N616) is 
an asparagine instead of the glutamine or arginine present in AMPARs, reports 
nevertheless observed bidirectional changes in the calcium selectivity of the 
mutant receptor contingent on N/Q or N/R mutation (Burnashev et al., 1992; 
Sakurada, Masu, & Nakanishi, 1993). Unexpectedly, though, these experiments 
also demonstrated significant attenuation of the magnesium sensitivity of the 




(2012) have shown that, while the sites 
probed by Burnashev et al. (1992) and 
Sakurada et al. (1993) participated in 
defining Mg2+ sensitivity, a single residue 
within the M3 domain of the GluN2 
subunit (S632 in GluN2A) coordinates 
with residues (largely W608) in the M2 
loop of GluN1 to primarily define the 
interacting site for Mg2+ action (for a 
schematic of basic GluN subunit 
topology see Figure 3). Additionally, 
comparison of residue homology 
between the four flavors of GluN2 
subunits (A-D) revealed that innately different substitutions at the respective 
homologous GluN2 M3 residues correlated significantly with both the intrinsically 
lower Mg2+ sensitivities observed with GluN2C/D-containing receptors versus 
their A/B counterparts as well as their intrinsically different relative Ca2+ 
permeabilities.  
Parsing the different glutamate-sensitive ion channels via pharmacological 
agents led many to wonder at the contributions of each receptor type in synaptic 
signaling. By recording currents in the presence and absence of the high potency 
NMDAR antagonist AP5, Jahr & Stevens (1987) dichotomized the receptor 
Figure I.3: General schematic depicting the 
broad topology of GluN subunits. As 
discussed, NMDARs are composed of 4 
such subunits, two glycine-binding GluN1 
and two glutamate-binding GluN2, in a 
complex. The S1 and S2 domains 
coordinate to define the extracellular ligand 
binding site, and the membrane-spanning 
domains, including the M2 reentrant loop, 




populations based on response times to glutamate activation into a “fast” 
component group comprised of AMPA and Kainate receptors, and a “slow” 
component group consisting largely of NMDARs. Importantly, this AP5-sensitive, 
slow component population appeared to exclusively govern the induction of 
synaptic potentiation after high frequency stimulation, leading others to speculate 
that activation of NMDARs was the mechanism underlying the most common 
forms of synaptic potentiation. The aforementioned study by Jahr & Stevens 
(1987) showed a high apparent calcium permeability of NMDARs, and results 
from subsequent studies showed that indeed NMDARs exhibit an exceptional 
selectivity for Ca2+ flux that by some estimates mediates upwards of 50% of total 
charge transfer during excitation (Murphy, Thayer, & Miller, 1987; Forsythe & 
Westbrook, 1988). The significance of this feature is discussed in further detail in 
Section I.8, though in short it was observed in later studies that this high Ca2+ 
permeability acted as a link in an elegant signaling cascade between NMDAR-
mediated activity and induction of activity of calcium-sensitive secondary effector 
proteins that drive synaptic strengthening. Interestingly, the studies discussed 
above demonstrating the dependency of Mg2+ sensitivity on individual residues in 
the reentrant M2 loop simultaneously revealed that these residues also govern 
the intrinsically high Ca2+ permeability of the NMDA receptor. 
The interaction of multiple amino acids and domains in establishing basic 
functional parameters of ion channels has become a guiding theme in 




foundation of comparative analysis in understanding the behavior of different 
receptor types. Indeed, until recently the AMPA receptor crystal structure served 
as the basis for hypothesized structures of the NMDA receptor (Sobolevsky, 
Rooney, & Wollmuth, 2002). Recently, however, the structure of the GluN2B-
containing NMDAR was solved simultaneously by two independent groups 
(Karakas and Furukawa, 2014; Lee et al., 2014). Such homology comparisons 
have proven essential to our understanding of ethanol action, and their 
implementation along with single channel electrophysiological recordings have 
enabled researchers to parse the discrete domains and gating steps that elicit 
channel activation (discussed more thoroughly in Section II.1). 
I.5 NMDARs Revealed to be Primary Sites of Ethanol Action 
 By this time, the broad strokes of innate NMDAR function and its role in 
synaptic transmission were rudimentally understood, but the question of how 
ethanol inhibited excitation remained open. As previously discussed in Section 
I.2, ethanol was shown, in addition to potentiating GABA-mediated inhibition, to 
directly affect excitatory post-synaptic activity (Nicoll, 1972). With the 
discrimination of three distinct excitatory, glutamate-sensitive receptor 
populations, divining substrate-specific actions of ethanol on neuronal excitation 
became possible. Seminal work by Lovinger, White, and Weight (1989) 
demonstrated that pharmacologically isolated NMDA currents were significantly 
inhibited by ethanol at concentrations associated with behavioral intoxication, 




attenuation at these concentrations. Given the emerging role of NMDARs in 
synaptic signaling, strengthening, and cognition, these results simultaneously 
aligned with behavioral manifestations of intoxication including depressed 
cognitive function and, with higher levels of intoxication, impairment of memory 
formation, as well as further intimated the elemental role of NMDARs in learning 
and memory. 
I.6 Mechanisms of Direct Inhibition of NMDAR Function by Ethanol 
 While Lovinger, White, and Weight (1989) showed that the NMDA 
receptor constitutes a primary site of ethanol action, it nevertheless remained 
unclear precisely how ethanol blunts NMDAR-mediated current. Early reports 
hinted that ethanol may interfere with glycine binding to the GluN1 subunit, and 
indeed such findings proved contentious from the start. Initially, experiments 
appeared to show that ethanol inhibition of NMDAR-mediated calcium influx in 
cerebellar granule cells and NMDA-stimulated dopamine release in striatal slices 
could be blunted by the addition of increasing concentrations of glycine (Rabe & 
Tabakoff, 1990; Woodward & Gonzales, 1990). Later experiments examining 
NMDA currents in hippocampal neurons showed no ethanol-induced shift in the 
glycine EC50 as would be expected with a competitive antagonist (Peoples & 
Weight, 1992). The matter would not seem definitively settled, however, until 
work by Mirshahi and Woodward (1995) demonstrated no shift in glycine EC50 
with ethanol application in recombinantly expressed GluN2A- and GluN2C-




due to differing glycine sensitivities of fully complemented receptors in intact 
tissue: indeed, studies have shown that glycine sensitivity of the GluN1 subunit is 
affected by what concomitant GluN2 subunit is expressed, such that otherwise 
comparatively ethanol-resistant receptor populations could be recruited with 
increasing glycine concentrations in native tissue (Peoples & Weight, 1992; 
Ronald, Mirshahi, & Woodward, 2001; Chen et al., 2008). Consistent among all 
studies, though, was the observation that ethanol did not directly compete with 
glutamate or NMDA binding, nor did ethanol affect the magnesium sensitivity of 
the channel (Chu, Anantharam, & Treistman, 1995; Bhave et al., 1996). Thus, it 
was determined that ethanol inhibits NMDAR function via non-competitive, 
voltage-independent mechanisms that are distinct from any actions as a pore 
blocker. 
 Subsequent single-channel experiments by Wright, Peoples and Weight 
(1996) ultimately showed that ethanol inhibited NMDA receptor activity by 
reducing mean channel open time and channel open probability, consistent with 
its role as an allosteric modulator of channel gating. Further work with NMDARs 
found that, while truncation of C-termini of GluN1 or GluN2 could modify the 
ethanol sensitivity of the NMDA receptor, it was primarily extracellular, not 
intracellular, application of ethanol that resulted in NMDAR inhibition, suggesting 
that, while the C-termini could modulate the ethanol sensitivity of the channel, 
these effects were likely subsequent to ethanol interactions with core gating 




receptor revealed that when specific residues within the transmembrane 2 (TM2) 
or transmembrane 3 (TM3) domains were mutated the alcohol-induced 
potentiation in current was significantly attenuated (Mihic et al., 1997). Based on 
this data, Ronald, Mirshahi and Woodward (2001) hypothesized that ethanol 
similarly acts as a modulator of NMDAR function by interactions with 
transmembrane elements. A homology scan of the TM domains in GluN1 and 
GluN2A-D subunits revealed a single residue in particular, F639 of GluN1 and 
the homologous sites in the modestly differentiated GluN2 subunits, of the TM3 
domain was highly conserved among NMDA subunits. Mutation of this residue in 
GluN1 elicited robust reductions in ethanol sensitivity that occurred regardless of 
what GluN2 subunit is expressed. Interestingly, attenuation of ethanol sensitivity 
appeared positively correlated with the volume of the substituent (i.e. - the most 
robust reductions in ethanol sensitivity were observed with smaller amino acids) 
(Smothers & Woodward, 2006). Recent studies, though, seem to both challenge 
and confirm this observation, as substitution of GluN1 F639 with a large 
tryptophan elicited attenuations in ethanol sensitivity comparable to GluN1 
(F639A) (Ren et al., 2012), while another study showed that GluN1 (F639C) 
restored wild type ethanol sensitivity following treatment with MTS reagents that 
covalently bind to cysteine residues, increasing their volume occupancy (Xu, 
Smothers, & Woodward, 2015). The discrepancy between these results remains 
an open question and will require further study. Functionally, substituent size also 
correlated positively (ie - smaller substituents displayed higher glycine sensitivity) 




occupancy within this molecular space partially governs reductions in channel 
activity (Smothers & Woodward, 2006). Importantly, this residue does not face 
the pore, both confirming prior data ruling out any actions of ethanol as a pore 
blocker while also intimating possible interactions with residues in other gating 
elements including TM4 (Mirshahi & Woodward, 1995).  
 In Ronald, Mirshahi and Woodward (2001) the authors were unable to 
generate functional receptors in X. laevis oocytes expressing GluN1/GluN2A 
(F637A) mutants, however subsequent work by Ren et al. (2007) using human 
embryonic kidney (HEK) cells did obtain functional receptors and found that 
manipulation of the GluN2A (F637) site resulted in profound effects on intrinsic 
receptor function distinct from those observed with GluN1 (F639A)/GluN2A 
receptors. Perhaps most importantly though, changes in ethanol potency seen 
with GluN1/GluN2A (F637X) were negatively correlated with the volume of the 
substituent amino acid (i.e. - increasing substituent size increasingly blunted 
ethanol sensitivity), in contrast to GluN1 (F639X)/GluN2A mutants in which a 
robust positive correlation was observed. Furthermore, with GluN1/GluN2A 
(F637X) receptors, the volume occupied did not significantly correlate with 
changes in mean open time of the channel, suggesting that this site in GluN2 
could instead act as a barrier to ethanol infiltration of adjacent sites (Ren et al., 
2007). Indeed, substituent-specific effects on basic channel properties would be 
expected if ethanol interacted directly with this site. The disparity between these 




GluN1 and GluN2 was initially attributed to a hypothesized structural shift of 
about 4 amino acids between the subunits (Sobolevsky, Rooney, & Wollmuth, 
2002). However, results from recent crystallographic studies of the 
GluN1/GluN2B structure show that this is not the case (Sobolevsky, Rooney, & 
Wollmuth, 2002; Karakas & Furukawa, 2015; Science; Lee et al., 2014). In 
addition, a recent study recapitulated the aforementioned experiments with 
GluN2B-containing receptors and obtained results similar to those seen with 
GluN2A-containing NMDARs were observed with GluN1/GluN2B (F637X) (Zhao 
et al., 2015).  
 
 This disparity between GluN1 and GluN2 TM3 mutations with regard to 
their effects on ethanol inhibition may reflect an intrinsic asymmetrical 
contribution of the subunits and their respective gating domains to receptor 
Figure I.4: Overhead view 
of the transmembrane 
domains that define the 
central ion-gating pore. 
Positions of GluN1 F639 
residues are shown relative 
to A825 residues in the M4 
domain of GluN2A. Note the 
size disparity between the 
two residues, as well as the 
seeming orientation of A825 
toward the lipid interface 
instead of a more direct 




function, consistent with emerging reports (Kazi et al., 2013). Indeed, work by Xu 
et al. (2012) has further shown that when GluN2A- and GluN2B-containing 
NMDARs are rendered constitutively open, they display GluN2-subtype specific 
changes in ethanol sensitivity. Specifically, it was observed that GluN2A-
containing receptors showed comparable decreases in ethanol sensitivity 
subsequent to either the GluN1 or GluN2 subunit being rendered open, with the 
larger effect observed with GluN2A. GluN2B-containing NMDARs on the other 
hand showed a robust decrease in ethanol sensitivity with GluN2 manipulation 
well above that observed with manipulation of GluN1, implying a higher 
proportional contribution of the GluN2B subunit to ethanol sensitivity in this 
receptor type. These data pose an interesting question; namely, whether the 
inherent difference in ethanol sensitivity observed between GluN2A- and 
GluN2B-containing NMDA receptor types is a product of intrinsically different 
gating mechanisms. This observation forms an essential part of the underlying 
hypothesis for the experiments discussed in Section II. 
 The central location of the F639 residue and the incomplete elimination of 
ethanol sensitivity of NMDARs following mutation at this site suggest that other 
sites may participate in channel inhibition. Further experiments discovered a 
residue, M823, in the TM4 domain of GluN2A that when mutated resulted in 
significantly attenuated ethanol sensitivity (Ren, Honse, & Peoples, 2003). The 
most robust attenuation of ethanol sensitivity was observed with mutation of 




other amino acid substitutions generally correlated negatively with spatial volume 
of the amino acid used. Importantly, though, manipulation of this site resulted in 
profound effects on basic channel properties including enhanced receptor 
desensitization, complicating an interpretation for M823 as a direct interacting 
site for ethanol. Thus, other residues proximal to the highly conserved M823 
were evaluated for effects on ethanol inhibition, ultimately resulting in 
identification of other candidate targets of ethanol action by Honse et al. (2004). 
The essential finding of this report was that manipulation of residue A825 in the 
TM4 of GluN2A resulted in a reduction in ethanol sensitivity over and above that 
observed with similar manipulations of not only M823, but as well residues distal 
and proximal to A825. Furthermore, manipulation of A825 resulted in few 
changes in intrinsic receptor function, in contrast to M823. Later experiments 
showed that the analogous residue in GluN2B, G826, could elicit similar 
reductions in ethanol sensitivity of the channel. Importantly, though, both alanine 
and especially glycine residues lack appreciable side-chains for direct ethanol 
interactions, and in the case of glycine, may be required to impart essential 
tertiary structure to the helix, thus limiting interpretation of this data as evidence 
for a true site of ethanol action (Smothers & Woodward, abstract presented at the 
Annual Meeting of the Society for Neuroscience, 2005; Zhao et al., 2015).  
 Caveats aside, the lack of intrinsic alterations in receptor function with 
mutation of GluN2A (A825)/GluN2B (G826) similarly distinguishes this site as a 




the effects observed with GluN1/GluN2 (F637) mutants. When both GluN1 
(F639A) and GluN2A (A825W) were co-expressed, an appreciable increase in 
ethanol IC50 over and above single mutants resulted, intimating that these sites 
do not specifically interact to regulate ethanol sensitivity (Ren et al., 2012). 
Indeed, by definition if these residues were truly epistatic in defining an alcohol 
site one would expect a non-additive effect on ethanol sensitivity subsequent to 
tandem site mutation. Because of this, other pairs of residues between GluN1 
TM3 and GluN2A TM4, as well as GluN1 TM4 and GluN2A TM3, were evaluated 
for potential interacting pairs that coordinate and define a site of ethanol action. 
The results indicated that residues adjacent to GluN1 (F639), G638 in particular, 
similarly resulted in robust increases in ethanol IC50 observed by Ronald, 
Mirshahi, and Woodward (2001) and that, along with F639, appeared to interact 
strongly with M823 and L824 in the TM4 of GluN2A. Neither residue, however, 
appeared to interact with A825 (see Figure I.4), consistent with structural models 
showing the side chain of A825 is pointed away from other proximal amino acids, 
and could be indicative of actions of ethanol on protein-lipid interactions 
(Sobolevsky, Rooney, & Wollmuth, 2002; Karakas & Furukawa, 2014; Lee et al., 
2014). Surprisingly, though, when cognate GluN1 TM4 and GluN2A TM3 pairs 
were evaluated the authors observed significant attenuations in ethanol 
sensitivity with individual mutation of GluN2A TM3 residues, but no apparent shift 
in ethanol IC50 subsequent to mutation of GluN1 TM4 residues. Indeed, if 
interactions between the GluN1 TM4 and GluN2A TM3 domains were truly 




shifts with single mutation of cognate GluN1 TM4 residues. Thus it appears the 
fundamental interactions of GluN1 TM4 and GluN2 TM4 with other receptor 
domains are likely very different, consistent with observations that GluN1 and 
GluN2 do not contribute homologously to channel activation (Banke & Traynelis, 
2003; Kazi et al., 2013; Cummings & Popescu, 2015). Residues L819 of GluN1 
and F637 of GluN2A, though, did appear to coordinate robustly in defining the 
desensitization rate of the channel, reinforcing models that implicate the 
movement of TM3 directly in ion channel gating with TM4 modulating gating 
indirectly via its interactions with TM3 (Jones, VanDongen, & VanDongen, 2002; 
Ren, Honse, & Peoples, 2003). Thus, from these experiments it can be 
concluded that ethanol interacts both directly with TM3 residues to impede 
channel gating as well as disrupts the modulatory functions of TM4 in the gating 
cascade, and suggests TM4 residues are more than simple barriers to ethanol 
access. 
 The participation of a canonical modulatory domain such as TM4 in 
defining ethanol sensitivity of the NMDAR suggests the possibility that similarly 
modulatory regions may participate as well. Indeed, a number of extracellular 
and intracellular domains within the NMDA receptor are known to impact channel 
activity. Specifically, work by Gielen et al. (2009) showed that the amino terminal 
domain (ATD) interacts robustly with the ligand binding domain (LBD) of the 
GluN2 subunit, substantially affecting the spontaneous opening/closure of the 




(2013) generated ATD-deleted GluN1 and GluN2 subunits and evaluated the 
ethanol sensitivity of these truncated mutants. Interestingly, the authors observed 
that deletion of the ATD of GluN2A subunit resulted in a significant increase in 
ethanol sensitivity of the receptor. While this effect could be attributable to relief 
of Zn2+ inhibition, this seems unlikely since prior reports by this laboratory 
showed that ethanol sensitivity was unchanged in receptors containing a point 
mutation that renders them zinc insensitive (Woodward & Smothers, 2003). A 
likelier explanation may instead rest on observations that ATD-deletion in 
GluN2A receptors results in reductions in channel open probability to similar 
levels seen with GluN2B receptors (Gielen et al., 2009). Therefore, in wild type 
GluN2A receptors, ethanol inhibition may be less substantial due to the 
intrinsically higher open probability as compared to GluN2B-containing receptors. 
ATD-deletion of GluN2A yields receptors with a lower open probability thus 
permitting an increase in the efficacy of ethanol (Smothers, Jin, & Woodward, 
2013). 
 Several studies have shown that in brain, pharmacological antagonism or 
genetic elimination of GluN2B renders residual NMDAR currents ethanol 
insensitive, suggesting that GluN2B-containing NMDARs constitute the primary 
site of ethanol action on NMDAR currents (Roberto et al., 2004; Kash, Matthews, 
& Winder, 2008; Wills et al., 2012). As GluN2B selective antagonists such as 
ifenprodil exert their effects via interactions with the ATD, these results suggest 




and Woodward (2013) study, however, robust inhibition of GluN2B-containing 
NMDAR current by ethanol was still observed in mutants lacking the ATD that 
abolished the effects of ifenprodil. This observation raises the possibility that, 
while ethanol and GluN2B-selective antagonists operate at different sites on the 
receptor, their effects on channel function converge. Indeed, others have shown 
that ifenprodil elicits reductions in mean open time and channel open probability 
in a fashion similar to those observed with ethanol (Wright, Peoples, & Weight, 
1996; Amico-Ruvio et al., 2012; Bhatt et al., 2013). Functionally, ATD-deletion of 
GluN2B results in no observable change in open probability, and further supports 
the conclusion that changes in open probability likely underlie the results seen 
with GluN2A ATD-deletion (Gielen et al.; 2009). In sum, it appears that the amino 
terminal domain, while a potent regulator of ligand-mediated channel gating, is 
not a primary site of ethanol action (Smothers, Jin, & Woodward, 2013). 
Nevertheless, probing the actions of the ATD on channel function has revealed 
that intrinsic receptor characteristics such as open probability partially dictate the 
differential ethanol sensitivities observed between GluN2 subtypes. These results 
are thus also important in informing the hypothetical basis for the experiments 
described in Section II. 
 I.7 Design-Specific Disparities in Ethanol Sensitivity Reveal Alternative 
Mechanisms of Alcohol Inhibition  
It is important to note that while the aforementioned studies consistently 




dose ranges appear to conflict with studies of NMDAR inhibition in neurons. 
Typical circulating blood levels of alcohol in an intoxicated person hover in the 
0.08-0.30 g/dL range and roughly correspond to millimolar concentrations of 17-
33. Most studies of ethanol action on recombinant NMDA receptors typically 
report ~30% inhibition of current with application of 60 mM ethanol, in stark 
contrast to the >60% inhibition observed by  Lovinger et al. (1989) (although this 
figure has since been amended by other experiments to a more generally 
accepted value of ~50%) (Chandler, Sumners, & Crews, 1993). This discrepancy 
highlights a potentially important disparity between native and recombinantly-
expressed NMDARs and suggests that additional factors likely participate in 
ethanol inhibition of NMDARs in vivo. Indeed, increasing evidence suggests the 
activity of kinases including Fyn tyrosine kinase potentiate NMDAR-mediated 
currents in neuronal tissue and blunt the ethanol sensitivity of this population. 
Further reports have modified this schema to include the activity of an NMDA-
interacting phosphatase, Striatal-enriched Tyrosine Phosphatase (STEP), that 
when knocked out in vivo appears to abolish ethanol sensitivity of NMDAR-
mediated current (Hicklin et al., 2011). As discussed more thoroughly in Section 
I.9, the action of these two secondary effectors on NMDAR-mediated currents 
appear to involve regulation of surface expression rather than direct actions on 
intrinsic receptor function. Nevertheless, while diametrically opposed, their 
mechanisms of action were both elucidated by experimental methods that 




 While the interplay of these mechanisms is discussed in greater detail 
later, it is prudent to further detail how the profound behavioral impairments 
observed with circulating levels of ethanol may differ from the relatively low level 
of NMDAR antagonism. This relationship between low efficacy and resulting high 
phenotypic response to NMDAR antagonism is not simply an idiosyncratic 
property of ethanol, as low doses of AP5 and resultant NMDA inhibition have 
similarly been shown to abolish NMDA-dependent up states in neuronal firing (Tu 
et al., 2007). This discrepancy implies not only a substantial role for NMDARs in 
cellular processes beyond simple signal propagation, but as well that in addition 
to direct actions on channel function these NMDA-dependent cascades may 
themselves be intrinsically sensitive to alcohol.  
 At the most basic level, the ability of drugs like ethanol to elicit substantial 
behavioral effects despite relatively modest inhibition of NMDARs may be related 
to the low levels of NMDAR expression at the synapse. Electron microscope 
studies of excitatory synapses have revealed that, unlike AMPA receptors, 
NMDA receptors exhibit a relatively intractable level of expression, averaging 
about 50 receptors per synapse regardless of size (Racca et al., 2000). AMPA 
receptors by comparison can vary widely in their expression, ranging from zero 
receptors in a synapse (a so-called “silent” synapse) to over 150 in large 
synapses (Nusser et al., 1998; Takumi et al., 1999). Thus the cumulative effect of 
50% inhibition of NMDAR-mediated current results in the silencing of half the 




profound implications when one considers the paramount importance of NMDA 
receptor signaling in processes including cortical up-states, learning, and 
memory. In the next section, then, I will provide a brief primer on the role of 
NMDA receptors in the machinery that governs synaptic plasticity, the molecular 
basis of learning and memory, and attempt to reconcile the disparate levels of 
alcohol inhibition on NMDA receptor signaling observed between reductionist, 
recombinant experiments and those conducted in neuronal tissue. 
I.8 NMDARs are Essential Regulators of Synaptic Plasticity 
 Excitatory glutamatergic synapses are morphologically defined by a 
feature called the post synaptic density (PSD) in which a host of scaffolding 
proteins assemble to form an extended matrix that incorporates a number of 
receptors and secondary effector proteins. Electron micrographs first revealed 
this structure as a large electron dense array embedded in spines along dendritic 
branches, and subsequent experiments established that PSD-containing 
synapses appear to be exclusively glutamatergic (Westrum & Blackstad, 1962; 
Allison et al., 1998). While successive reports continue to elucidate the finer 
points of PSD function, the central role of the PSD is to act as a molecular hub 
for the efficient transduction of trans-synaptic signaling between ion channels 
and secondary effector proteins that regulate receptor expression as well as 
basic cellular function (for review see Kennedy, 2000). Structurally, the PSD is a 
conglomerate of scaffolding proteins largely composed of membrane-associated 




An essential feature of MAGUKs are the presence of multiple PDZ domains that 
allow the formation of peptide bonds with a number of different proteins 
simultaneously, ultimately permitting the assembly and organization of large, 
diverse signaling complexes at the cell membrane (Doyle et al., 1996; Hsueh, 
Kim, & Sheng, 1997). In tandem with cycling of the actin cytoskeleton between 
filamentous and globular forms, the integration and disintegration of MAGUK-
protein interactions represent the most basic form of excitatory synaptic plasticity 
(Allison et al., 1998). 
 Interestingly, among the first MAGUK-interacting proteins discovered was 
the NMDA receptor, and indeed a large majority of neuronal NMDA receptors are 
found within this molecular milieu (Kornau et al., 1995; Niethammer, Kim, & 
Sheng, 1996). Many subtypes of NMDARs, though most notably GluN2A- and 
GluN2B-containing receptors, have extensive C-termini with myriad different 
consensus sequences that recognize not only PDZ domains but as well a host of 
different kinases and phosphatases (Kornau et al., 1995; Niethammer, Kim, & 
Sheng, 1996; Zhou et al., 2007; for review see Salter and Kalia, 2004). As 
previously discussed in Section I.4, NMDA receptors display unique channel 
characteristics including voltage dependence and a high calcium permeability 
relative to other glutamatergic ion channels. These properties in conjunction with 
an apparent affinity for C-terminal protein-protein interactions led many to 




between membrane depolarization and induction of cytoskeletal rearrangements 
associated with activity-dependent phenomena including long term potentiation. 
 Donald Hebb first postulated that learning was the aggregate result of 
distributed synaptic strengthenings, specifically positing that repeated pre-
synaptic stimulations at a synapse would elicit enhanced post-synaptic 
responses over time. Owing to its veracity, this model has since been termed 
“Hebbian plasticity” (Hebb, 1949). It would not be until 1973, however, that this 
phenomenon would be experimentally described when Bliss and Lomo (1973) 
observed heightened synaptic responses in the dentate gyrus subsequent to high 
frequency stimulation of the perforant pathway stimulation. While the particulars 
of that phenomena, which they dubbed “long term potentiation” (hereafter 
referred to as LTP), vary, it is generally understood to constitute enhanced 
synaptic transmission after induction that persists for >30min and is often, though 
not always, post-synaptic and NMDA-dependent (for review see Nicoll & Roche, 
2013). For the purposes of this discussion only NMDA-dependent LTP will be 
addressed. 
 The observation of synaptic LTP posed two important questions: namely, 
(1) what type(s) of receptors mediate this phenomenon, and (2) by what 
mechanism do these receptors induce synaptic potentiation? Using a variety of 
pharmacological agents Collingridge, Kehl, and McLennan (1983) demonstrated 
that kainate and AMPA receptors largely mediate fast excitatory synaptic 




somewhat counter-intuitively, the authors observed that application of an 
NMDAR-selective antagonist, DL-AP5, blocked the induction of synaptic 
potentiation, heavily implying a central role for the NMDA receptor in governing 
LTP. Additional experiments further showed that, while NMDARs are essential 
for the induction of LTP, AMPA-mediated currents appear to underlie the actual 
expression and maintenance of enhanced synaptic signaling, suggesting 
NMDARs are themselves not significantly potentiated (Muller, Joly, & Lynch, 
1988; Davies et al., 1989). 
 As discussed previously, a number of idiosyncratic features make the 
NMDA receptor uniquely suited to fulfill a role as a central hub for coordinating 
synaptic signaling with the mechanics of synaptic strengthening. Among these 
features is the inherent voltage-dependent blockade of NMDARs by magnesium, 
whose relevance to long term potentiation became apparent subsequent to work 
published by Herron et al. (1986). In this study, the authors showed that induction 
of LTP was frequency-specific, requiring high levels of stimulation to relieve this 
magnesium block and allow ion flow through NMDARs. Thus, in concert with the 
NMDA receptor’s intrinsically high calcium permeability, voltage-dependent 
magnesium blockade permits the NMDA receptor to act as a coincidence 
detector linking post-synaptic depolarization, via synaptic activation of 
AMPA/Kainate receptors, back-propagating depolarization from firing of an action 





 Importantly, initial studies of LTP showed that expression of the 
phenomenon was not only sensitive to extracellular concentrations of Mg2+, 
consistent with a central role for NMDARs in eliciting LTP, but to levels of free 
calcium as well (Dunwiddie & Lynch, 1979). Further experiments by this group 
revealed that high frequency stimulation of hippocampal tissue in low-calcium 
extracellular solution did not exhibit enhanced binding of tritiated glutamate 
observed with normal calcium levels, indicating calcium may be essential to post-
synaptic mechanisms of potentiation (Lynch, Halpain, & Baudry, 1982). By 
intracellularly injecting EGTA, a calcium chelator, into the post-synaptic neuron, 
Lynch et al. (1983) determined that LTP is indeed a post-synaptic phenomenon, 
dependent on influx of extracellular Ca2+ into the post-synaptic neuron, later 
shown to occur specifically via influx through NMDA receptors (Frank et al., 
1989). 
Though at this point it was understood that the long-term cellular 
processes induced by NMDA activity relied significantly on calcium flux through 
NMDARs, the ultimate consequence of this calcium influx was not known. Davies 
et al. (1989) observed slow increases in the sensitivity of neurons to 
iontophoretically-applied AMPA receptor agonists after induction of LTP 
suggesting AMPARs mediate the expression of LTP. It remained unclear, 
however, if this was due to a functional change in the unitary conductance of the 
AMPA receptor or to increased AMPAR expression. More fundamentally, though, 




facilitation was lacking. Owing to the vast expression of Ca2+/calmodulin-
dependent protein kinase II (CaMKII) in the forebrain, by some estimates 
comprising nearly 2% of the total protein, CaMKII began to emerge as a possible 
intermediary in this cascade (Erondu & Kennedy, 1985). Experiments conducted 
by Malinow, Madison, and Tsien (1988) were among the first to pose and test the 
hypothesis that induction of protein kinase activity could link Ca2+ influx through 
NMDARs to enhancement of AMPA-mediated currents. Using intracellular 
injection of calmidazolium, a calmodulin antagonist, it was further shown that 
activation of CaMKII, a dodecameric kinase activated by calcium-bound 
calmodulin, is required for eliciting post-synaptic potentiation (Malenka et al., 
1989). Importantly, experiments showed that the role of NMDA receptors in 
CaMKII activity was two-fold: namely, Ca2+ influx through NMDARs activated 
calmodulin binding to CaMKII, and the extensive C-terminal tails of GluN2 
subunits (GluN2B in particular) act as molecular scaffolds for CaMKII to 
autophosphorylate its own regulatory domains thus further enhancing activity 
(Strack & Colbran, 1998; Leonard et al., 2002; Bayer et al., 2001). 
While the observed effects of CaMKII antagonists on LTP suggested a 
necessary role for the protein, the final link between CaMKII activity and 
upregulation of AMPA current remained an open question. A tentative answer 
emerged when experiments by Tan, Wenthold, and Soderling (1994) showed 
that treatment of cultured hippocampal neurons with stimulators of CaMKII and 




that was blocked by pretreatment with the NMDA receptor antagonist AP5, or 
KN-62, a CaMKII inhibitor. Later studies ultimately showed that AMPA subunits, 
GluA1 in particular, displayed CaMKII consensus sequences that exhibited a 
strong positive correlation between their phosphorylation state and the 
magnitude of AMPA current potentiation (Barria et al., 1997; Mammen et al., 
1997; Barria, Derkach, & Soderling, 1997). While contemporaneous evidence 
suggested that phosphorylation of AMPAR subunits was itself sufficient to 
increase AMPA-mediated current (Raymond, Blackstone, & Huganir, 1993), 
other mechanisms likely mediated upregulated AMPA current after LTP 
induction. Indeed, experiments performed by Ehlers (2000) demonstrated that 
elevated levels of synaptic activity could induce reinsertion of endosomally bound 
AMPARs into the plasma membrane. Further work similarly showed that 
induction of LTP critically relied on AMPA receptor insertion into the plasma 
membrane, definitively demonstrating that LTP-induced upregulation of AMPA 
current was the product of receptor phosphorylation that then signaled 
membrane targeting (Lu et al., 2001). Refinements to this model continued to 
emerge, ultimately revealing that differential subunit phosphorylation drove not 
only GluA1-containing AMPAR insertion into the membrane, but as well 
simultaneous GluA2-containing receptor internalization (Chung et al., 2000; 






While the mechanism of LTP thus described represents only one of a 
number of NMDA-dependent forms of plasticity, it nevertheless highlights the 
multiple interactions and events that NMDA receptor activity governs that guide 
and shape homeostasis. That homeostasis is itself such a dynamic process has 
led many to question whether drugs of abuse impair or co-opt this innate 
machinery to drive drug-seeking behavior. Indeed emerging evidence suggests 
dysfunction in NMDA receptor homeostasis is, if not a primary etiology, a 
secondary pathology of extended alcohol exposure that seems to promote 
maladaptive seeking behaviors. The dichotomy of alcohol action between acute 
Figure I.5: Many forms of plasticity are 
NMDA dependent. Panel (a.) 
demonstrates that after high frequency 
stimulation (usually 3-4 1 sec bursts of 
100 Hz stimulation) current amplitudes 
of the recorded neuron increase 
substantially, and remain elevated for 
hours after LTP induction. When an 
NMDA antagonist (AP5) is present 
during stimulation, though, LTP is not 
induced. Panel (b.) illustrates the 
molecular mechanisms underlying 
observed increases in current amplitude 
following LTP induction. 1.) High 
frequency stimulation causes AMPARs 
to open, relieving Mg
2+
 blockade of 
NMDARs and permitting subsequent 
Ca
2+
 influx. 2.) Ca
2+
 then binds 
Calmodulin, activating CaMKII (purple), 
that then 3.) phosphorylates 
endosomally-bound AMPA receptors, 
4.) signaling their insertion into the 
plasma membrane. The net result is 




inhibition of NMDAR function and secondary disruptions of NMDA-dependent 
plasticity and homeostasis is an interesting phenomenon, and indeed it remains 
unclear as to whether the two events are mutually exclusive. This suggestion 
forms the hypothetical basis for experiments detailed in Section III. In any case, 
the alcohol-induced changes in NMDA receptor function and expression with 
chronic exposure appear to be driven by mechanisms distinct from those 
described that drive LTP, and constitute a form of “meta-plasticity”, in which the 
regulators of plasticity themselves become the targets of modulation, and serves 
to further underscore the critical importance of NMDARs in pathology of 
alcoholism. 
I.9 Homeostatic Changes in NMDA Receptor Expression After Extended Alcohol 
Exposure 
 Given the pivotal role of the NMDA receptor in eliciting plasticity, inhibition 
of its activity should have profound effects on normal synaptic function even with 
low levels of antagonism, echoing the point made in Section I.7. Furthermore, the 
previously detailed two-fold role of NMDARs in eliciting plasticity, specifically their 
high innate calcium permeability and predisposition to act as a molecular 
scaffold, explains the high phenotypic response to relatively modest levels of 
NMDA antagonism by alcohol. In fact, as will be detailed, substantial evidence 
has emerged suggesting that alcohol inhibits not only NMDAR channel gating, 
but additionally alters the regulation of receptor surface expression in a highly 




Although results from initial experiments by Peoples and Stewart (2000) 
discounted a role of intracellular domains in mediating the direct actions of 
alcohol on NMDA receptor function, the prevalence of studies suggesting that 
secondary effector proteins known to associate with NMDARs could influence 
ethanol sensitivity in neurons nevertheless accumulated. Among the first reports 
describing this phenomena were observations by Miyakawa et al. (1997). In this 
study, knockout of Fyn, a neuronally enriched tyrosine kinase and intimate 
associate of NMDA receptors, in mice resulted in the elimination of acute 
tolerance to ethanol inhibition typically seen with extended alcohol application. 
This finding fostered other studies to determine what role, if any, kinases had in 
governing the sensitivity of NMDARs to acute ethanol exposure.  
Chief among these was a report by Anders et. al. (1999) that showed a 
robust reduction in ethanol sensitivity, and concomitant increase in tyrosine 
phosphorylation, of recombinantly expressed GluN2A-containing NMDARs when 
co-expressed with Fyn. Oddly, though, no effect was seen with co-expression of 
Fyn and GluN2B-containing NMDARs, that displayed similar increases in 
tyrosine phosphorylation as GluN2A and that is known to intimately associate 
with Fyn (Salter and Kalia, 2004). Later work by this laboratory ultimately 
demonstrated that the effect of Fyn co-expression on GluN2A ethanol sensitivity 
was due to Fyn-mediated relief of tonic Zn2+ inhibition, consistent with 
observations that the phosphorylation state of C-terminal tyrosines on GluN2A 




Nevertheless, the kinase-mediated reductions in ethanol sensitivity reported by 
these authors, though statistically significant, appeared modest at best and such 
receptors retained significant amounts of inhibition. Indeed, evaluation of co-
expression of other kinases or mutation of C-terminal consensus sites of 
phosphorylation revealed only slight or no changes in ethanol sensitivity of 
recombinantly expressed NMDARs (Anders et al., 1999; Xu, Chandler, & 
Woodward 2008; Xu, Smothers, & Woodward, 2011). Furthermore, single 
channel studies of NMDARs have shown that phosphorylation state of C-terminal 
residues appear to impact channel function, underscoring this disparity and 
ultimately becoming an essential justification for the experiments detailed in 
Section III (Murphy et al.; 2014 : Aman et al.; 2014). 
Irrespective of these aforementioned conflicts in data, substantial 
evidence simultaneously emerged that the phosphorylation state of NMDAR C-
terminal residues correlated significantly with receptor surface expression. While 
association of kinases and phosphatases with NMDARs was already 
documented, a report by Hall and Soderling (1997) was among the first showing 
that under basal circumstances, neuronal NMDARs exhibit extensive GluN2 
subunit phosphorylation. This increases following cell stimulation with glutamate 
application and GluN2 phosphorylation correlates significantly with receptor 
inclusion in the plasma membrane (Wang & Salter, 1994). Strangely, the authors 
reported that primarily serine, not tyrosine, residues accounted for this increase 




subunits display extensive tyrosine phosphorylation after induction of LTP (Lau & 
Huganir, 1995; Rostas et al., 1996). This discrepancy may have been due to the 
use of dispersed cultured neurons by Hall and Soderling, as opposed to use of 
intact tissue employed by others, since these cells are not fully developed and 
exhibit lower levels of tyrosine kinase expression, including Fyn (Yagi et al., 
1994). Nevertheless, this spurred others to investigate the role of post-
translational modifications of GluN2 C-termini in the regulation of receptor 
surface expression, culminating in the elucidation of a highly dynamic and 
subunit-selective process that is inherently alcohol-sensitive. 
While Miyakawa et al. (1997) demonstrated an essential association of 
Fyn and GluN2B-containing NMDARs in mediating acute ethanol tolerance, 
further revelations by Yaka et al. (2002) and others showed that extensive 
interactions between a host of secondary effector molecules coordinated during 
basal and post-stimulation conditions effectively govern the relative surface 
expression of predominantly GluN2B-containing NMDARs (Roche et al., 2001; 
Lavezzari et al., 2003; Prybylowski et al., 2005). This GluN2B-dependency 
specifically seems to be due to the presence of the high-consensus YEKL 
(tyrosine-glutamate-lysine-leucine) domain at the extreme C-terminus that 
promotes binding of adapter protein 2 (AP-2) (Roche et al., 2001; Lavezzari et 
al.; 2003). As its name implies, the function of this protein largely consists of 
acting as an adapter between the substrate, in this case the GluN2B subunit of 




assembles into cage-like structures forming endosomes that ultimately internalize 
the AP-2-bound substrate. Importantly, the binding of AP-2 to the YEKL site on 
GluN2B is intimately determined by the phosphorylation state. Specifically, AP-2 
will only bind when Y1472 of this consensus site is dephosphorylated. Thus, the 
Fyn-dependent acute tolerance to ethanol observed by Miyakawa et al. (1997) 
could have been a product of blunted AP-2 association subsequent to 
heightened phosphorylation of GluN2B, and indeed later work by Yaka et al. 
(2002), Yaka, Phamluong, and Ron (2003), and Wang et al. (2007) has since 
borne out this mechanism. In addition, work by these authors and others has 
modified this schema to include the essential ethanol-sensitive element RACK1 






Thus, the induction of Fyn activity, potentially via enhanced Dopamine D1 
receptor signaling, following ethanol administration appears to be a homeostatic 
mechanism that restores NMDAR-mediated current blunted by ethanol (Wang et 
al., 2010; Xu et al., 2015). This effect is observed functionally as a rebound in 
NMDAR current over and above baseline levels that is apparent following alcohol 
washout. The effector cascade described above likely underlies this 
phenomenon specifically by heightening Y1472 phosphorylation, thereby 
blocking AP-2 binding to GluN2B and ultimately both stabilizing NMDAR surface 
expression and facilitating the insertion of endosomal pools of NMDA receptors 
into membrane. This increase in surface-bound receptors is opposed to 
functional up-regulation via enhanced unitary conductance, etc. based on the 
Figure I.6: Diagram of 
repeated ethanol exposure on 
NMDA receptor expression. 
Panel (a.) shows how Fyn-
mediated phosphorylation 
promotes the insertion of 
endosomal pools of NMDARs 
into the plasma membrane. 
Panel (b.), adapted from 
Wang et al. (2010), shows the 
cumulative effect on NMDAR-
mediated current of ethanol-
induced Fyn activity. Ethanol 
treatment enhances 
Dopamine D1 receptor 
signaling (1.), inducing Fyn 
activity (2.), that promotes 
NMDAR insertion into the 
plasma membrane (3.), 




previously detailed work of Anders et al. (1999), Xu et al. (2008), and Xu et al. 
(2011). Interestingly, repeated induction of this phenomenon in dorsal striatum by 
cycles of ethanol administration appears to result in persistently heightened 
NMDAR signaling well above baseline, and has been given the moniker “long-
term facilitation” by Wang et al. (2007). Long-term facilitation appears essential to 
the pathogenesis of maladaptive behaviors with chronic alcohol exposure, and its 
expression in dorsomedial striatum appears sufficient to drive elevated alcohol 
drinking behaviors (Wang et al., 2010). 
While an attractive mechanism for acute tolerance observed with ethanol 
exposure, the converse seemed equally plausible for governing acute inhibition 
by ethanol: specifically, that ethanol-induced dephosphorylation of GluN2B, 
subsequently provoking internalization of the receptor complex by AP-2, may 
partially underlie ethanol inhibition and resolve the disparate observations in 
ethanol sensitivity noted between recombinant and native tissue experiments. 
Indeed, building on an accumulating body of evidence showing high interacting 
specificity of striatal-enriched protein tyrosine phosphatase (STEP) with GluN2B, 
Wu et. al. (2010) showed that not only did ethanol exposed neuronal tissue 
exhibit significant dephosphorylation of GluN2B C-terminal tyrosine residues (e.g. 
– Y1252, Y1336, and Y1472), but that such ethanol treatment also correlated 
with increased STEP33, a soluble form of STEP, expression (Snyder et al., 2005; 
Kurub et al., 2010). Further work by this group ultimately showed that in brain 




inhibition was observed. Interestingly though, and consistent with the canonical 
functions of Fyn suggested by Miyakawa et al. (1997) and Wang et al. (2007), 
compensatory facilitation of NMDAR-mediated current was still observed 
following ethanol washout.  
 
 
Still unclear, however, is in what manner these opposing cascades are 
induced, and indeed whether or not they are in fact mutually exclusive. Emerging 
reports suggest that a central factor temporally distinguishing STEP-mediated 
Figure I.7: Diagram showing ethanol-induced STEP activity resulting in diminished NMDAR-
mediated current. 1.) Ethanol initially blocks NMDAR current via direct interactions with the 
receptor, but with extended application induced the activity of STEP. 2.) STEP 
dephosphorylates C-terminal tyrosine residues on GluN2B, signaling the binding of AP-2 
(orange) to GluN2B, ultimately recruiting clathrin (purple) resulting in endocytosis of affected 
NMDAR complexes. 3.) The net result is diminished NMDAR current. After washout of 
ethanol, the endosomally-bound NMDARs can be targeted either for proteolytic degradation, 




NMDAR down-regulation and Fyn-mediated compensatory up-regulation is 
ethanol-induced facilitation of activity of the dopamine D1 receptor (Xu et al., 
2015). Specifically, induction of PKA activity by ethanol/D1 results in STEP 
inhibition, resulting in PTPα dis-inhibition (a regulator of Fyn activity) that 
ultimately dephosphorylates regulatory sites on Fyn permitting up-regulation of 
NMDAR-mediated current. This model is consistent with previous work showing 
persistent up-regulation and synaptic targeting of GluN2B-containing NMDARs 
that was PKA dependent and that may represent a sensitization of the system to 
ethanol-induced synaptic plasticity (Carpenter-Hyland, Woodward, & Chandler, 
2004; Wang et al., 2007; Clapp et al., 2010). That this paradigm does not include 
a basis for ethanol-induced STEP activity is curious and seems to argue that 
STEP up-regulation is not necessarily a primary feature of alcohol inhibition of 
NMDA receptors. Indeed, while others have shown that enhanced 
phosphorylation of GluN2B by Fyn does not result in any appreciable increase in 
unitary enhancement of receptor function, the converse experiment, whether 
dephosphorylation of STEP-interacting residues on GluN2B directly affects 
channel function and ethanol sensitivity, is as yet untested and represents a gap 
in the literature that studies outline in Section III has sought to fill.  
I.10 Differential Ethanol Sensitivity of NMDAR Subtypes: Implications for 
Compensatory Plasticity 
 As discussed, the NMDA receptor is a critical link in a number of cellular 




that in addition to the acute effects of ethanol on receptor function, extended 
application can result in the recruitment of adaptive mechanisms that up-regulate 
receptor function and restore homeostasis. Such maladaptive changes in the 
activity of these metaplastic elements are not only persistent but have been 
shown to drive pathological behaviors. Though these late phase mechanisms of 
NMDAR regulation display an apparent preference for GluN2B-containing 
NMDARs, it is important to remember that NMDAR populations exist as a rich 
milieu of subtypes at most synapses and that accumulating evidence shows 
exhibit differential sensitivities to ethanol depending on GluN2 subtype. The 
significance of this becomes apparent when considering work by Foster et al. 
(2010) and Kim et al. (2005) demonstrating vastly different roles for GluN2A- and 
GluN2B-containing NMDARs in eliciting specific types and magnitudes of 
synaptic plasticity. Thus a fundamental understanding of how ethanol 
preferentially inhibits these receptor subtypes could reveal the relative 
contribution of these receptor types in the pathogenesis of alcoholism. This 
question, in concert with the possible extraneous intramolecular sites of alcohol 
action on the NMDA receptor outlined in Section I.6, thus represents the driving 





Chapter II. Differential Gating of GluN2A and GluN2B Receptor Types 
Govern Ethanol Sensitivity 
II.1 Introduction 
 As discussed extensively in Section I, the NMDA receptor is an essential 
mediator of excitatory neurotransmission, and in addition acts as a central link 
that transduces levels of excitation into long term cellular adaptations. NMDARs 
are large, tetrameric complexes composed of two obligate, glycine-binding GluN1 
subunits and two glutamate-binding GluN2 subunits and each display their own 
unique intramolecular interacting sites, as well as vastly divergent sites of 
intermolecular interaction such as their extensive intracellular C-termini. Owing to 
its prominence in forebrain signaling, NMDA receptor dysfunction has been 
implicated in a number of pathological states including addiction and 
schizophrenia (Cull-Candy et al., 2001). In addition to their innate gross 
complexity is the potential inclusion of 8 different splice variants of GluN1 as well 
as four different isoforms of GluN2 subunits that themselves can vastly affect the 
functional properties and intermolecular interactions of the fully complemented 
receptor. It is perhaps unsurprising, then, that a precise understanding of how 
ethanol inhibits these channels remains elusive. Nevertheless, work by our 
laboratory and others have identified a number of key sites within the core 
membrane-spanning (M) elements that, when mutated, can substantially alter the 




 Two sites in particular, F639 in the M3 domain of GluN1 and A825 in the 
M4 domain of GluN2A, robustly diminish ethanol sensitivity when mutated to a 
smaller alanine (A) residue or larger tryptophan (W) residue respectively (Ronald 
et al., 2001; Ren et al., 2003; Smothers and Woodard, 2006). When the 
analogous M3 residue of GluN2A, F637, was mutated, however, no apparent 
change in ethanol sensitivity was observed, suggesting non-homologous roles for 
GluN1 and GluN2 transmembrane elements in dictating ethanol sensitivity (Ren 
et al.; 2008). Furthermore, studies by our laboratory and others have shown that 
not only does NMDAR sensitivity to ethanol vary in a GluN2 subtype-dependent 
fashion (e.g. between GluN2A and GluN2B subtypes), but that mutating 
homologous M4 sites of alcohol activity between GluN2A and GluN2B (e.g. -  
A825W and G825W) also elicits unequal alterations in ethanol sensitivity similarly 
described above between GluN1/GluN2 M3 residues (Xu et al., 2012; Zhao et al., 
2015; Hughes and Woodward; unpublished observations).  
 





Kinetic modeling of NMDA receptor gating developed by Popescu and 
Auerbach (2004) has shown that, while the transmembrane elements are core 
determinants of channel gating, other extracellular sites also govern channel 
activity. Specifically, work by Kazi et al. (2013) has shown that the linker regions 
between the S1/M1 and S2/M4 domains participate strongly in unequally 
assigning GluN subunit participation in the gating cascade, with the GluN2 
subunit in particular predominantly determining the final closed to open transition 
state. Their results also revealed that conformationally restricting the movement 
of these linkers by cysteine-crosslinking elicited reductions in open probability 
and mean open time of the channel that strongly resembled those observed in 
wild type receptors exposed to ethanol (Wright et al., 1996; Kazi et al., 2013). 
Indeed, Smothers and Woodward (2006) showed that receptors containing both 
the GluN1 F639A and GluN2A A825W mutations still displayed residual 
sensitivity to alcohol, suggesting other sites of alcohol action. 
 Thus, via conformationally restricting or enhancing mobility of these linker 
regions, we sought to evaluate a three-fold hypothesis: 1.) Changes in linker 
domain mobility will significantly alter ethanol sensitivity, 2.) Altering linker 
domain mobility will reveal fundamentally different gating profiles between 
Figure II.1: The left panel shows concentration-response relationships between wild type 
and mutant GluN2A- and GluN2B-containing NMDA receptors expressed in HEK cells with 
acute application (10 sec) of increasing concentrations of ethanol. The right panel shows 
the quantification of the effects of M4 residue mutation on ethanol IC50 values (left panel), 





GluN2A- and GluN2B-containing NMDA receptors, and 3.) The essential gating 
differences between GluN2A- and GluN2B-containing receptors will partially 
explain the intrinsic differences in ethanol sensitivity between the receptor 
subtypes. Experimentally, we have chosen to exploit the phenomenon of 
cysteine substitution and disulfide crosslinking described by Kazi et al. (2013) to 
restrict linker mobility, in which intra-domain proximal residue pairs are mutated 
to cysteines and allowed to spontaneously form disulfide bridges, restricting the 
movement of that region. Increasing the mobility of the linker regions was 
accomplished by substituting select intra-domain residues to a rotationally active 
glycine residue.  
II.2 Materials and Methods 
Cell culture and mutagenesis 
Human embryonic kidney (HEK) 293 cells were obtained from ATCC 
(Manassas, VA) and maintained in 10 cm culture dishes containing serum-
supplemented DMEM in a humidified incubator with 5% CO2. For recordings, 
cells were split and plated on poly-ornithine coated 35 mm dishes and 24 hrs 
later transfected with cDNA plasmids using Lipofectamine 2000 (Invitrogen Inc, 
Carlsbad, CA). Plasmids containing rat GluN1, wild-type or mutant rat GluN2A or 
GluN2B, and an enhanced green fluorescent protein for cell selection were 
transfected at a 3:3:1 ratio unless otherwise noted. All mutant receptor subunits 
were generated using the Quik Change II site-directed mutagenesis kit (Agilent 




(Genewiz, South Plainfield, NJ). Residues selected for cysteine substitution were 
specifically derived from Kazi et al. (2013) and are as follows (residue numbering 
schema used by Wollmuth laboratory indicated in parentheses): Intra-GluN1 
M1:M4 = S549 (531):F810 (792), Intra-GluN2A M1:M4 = V544 (525):D815 (796), 
Intra-GluN2B M1:M4 = V545 (526):D816 (797), Inter GluN1 M4:GuN2A M1 = 
P805 (787):S554 (535), Inter GluN1 M4:GluN2B M1 = P805 (787):S555 (536). 
These residues were previously shown in Kazi et al. (2013) to only exhibit 
crosslinking when expressed in tandem, with no change in receptor function 
observed in single cysteine mutants. Prior to transfection, cell media was 
exchanged for fresh media containing 5 mM MgCl2 and 0.5 mM AP5 (Abcam, 
Cambridge, MA) to prevent excitotoxic cell death. Experiments were conducted 
24 hrs post-transfection and after extensive washing to remove NMDA 
antagonists. 
Electrophysiological recordings 
Dishes containing transfected cells were mounted on an Olympus IX50 
inverted microscope (Waltham, MA) and were perfused with an extracellular 
solution at a rate of 1-2 mL/min at room temperature. Extracellular recording 
solution contained the following (in mM); NaCl (135), KCl (5.4), CaCl2 (1.8), 
HEPES (5), glucose (10), (pH adjusted to 7.4 with 1 M NaOH, and osmolarity 
adjusted to 315-325 mOsm with sucrose). Patch pipettes (2-5 MOhms) were 
pulled from standard wall borosilicate glass (1.5 x 0.85 mm) and filled with 




(5), HEPES (10), NaATP (2), NaGTP (0.3), (pH adjusted to 7.2 with 2 M CsOH, 
and osmolarity adjusted to 290-295 mOsm with sucrose). Transfected cells were 
identified by eGFP fluorescence and whole-cell voltage clamp recordings were 
performed using an Axon Instruments 200B microamplifier (Molecular Devices, 
Union City, CA). Cells were held at -70 mV to monitor breakthrough and 
maintained at this potential unless otherwise noted. Access resistance was 
monitored throughout the experiment and cells demonstrating unstable holding 
currents or significant changes in series resistance were excluded from analysis. 
NMDA currents were evoked using a Warner FastStep multi-barrel perfusion 
system (Hamden, CT) programmed to switch between extracellular recording 
solution and solution containing agonist (10 µM glutamate and glycine) or agonist 
plus ethanol (30-300 mM). For cysteine crosslinking experiments, once all 
concentrations of ethanol were tested, cells were treated with 10 mM DTT for 20 
seconds immediately followed by three consecutive 2-sec pulses of 10 µM 
Glu/Gly. These responses were used to determine percent DTT-potentiation by 
comparing them to the mean of currents obtained in the same cell during the 
ethanol experiments. Glutamate concentration-response curves were acquired 
by increasing the concentration of glutamate from 0.1-30 µM for GluN2A 
experiments, and 0.03-10 µM for GluN2B experiments. The order of solutions 
was interleaved to account for any time-related effects. For MK-801 decay 
experiments, 5 µM MK-801 (Sigma-Aldrich, St. Louis, MO) was applied in the 
continuous presence of 10 µM glutamate/glycine for 7.5 seconds, then the cell 




and acquired at 5 kHz using an Instrutech ITC-16 digital interface (HEKA 
Instruments, Bellmore, NY) and analyzed offline by Axograph X software 
(Axograph Scientific, Sydney, NSW, Australia). Ethanol was purchased from 
Pharmco-Aaper (Brookfield, CT) and all other chemicals were obtained from 
Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
Data analysis 
For glutamate concentration-response experiments, Prizm 6.0 software 
(GraphPad Software, San Diego, CA) was used to calculate EC50 and Hill 
coefficient via the equation y = Emax / (1 + 10^((Log{IC50 or EC50} - Log[x])* nH)), 
where Emax is the maximum current evoked, nH is the Hill coefficient, y is the 
measured response amplitude, and [x] is the concentration of glutamate. Curves 
were fit to data obtained from individual cells with the minima and maxima 
constrained to zero and 100 respectively, and derived log EC50 values were 
statistically compared using one-way analysis of variance (ANOVA) and 
Dunnett's post test. All values are reported as mean ± S.E.M. Note that in Figure 
6 all mutants were analyzed simultaneously with those in Figure 5F and only 
divided into separate graphs for clarity. For ethanol experiments, a two-way 
ANOVA with Dunnett's post test was used to statistically compare mutation-
dependent changes in ethanol sensitivity across doses versus wild type. In DTT 
experiments, responses from individual cells were analyzed using a one-sample 
t-test (control set to 100%) followed by inter-group comparison using one-way 




exponential function was fit to the MK-801-induced current decay for each cell 
using the curve fitting routine in AxographX (Axograph Scientific, Sydney, NSW, 
Australia), and the time constant of inhibition was then used to calculate the rate 
of inhibition (1/τMK-801). 
II.3 Results 
 
Figure II.2: Sequence of extracellular linkers and structural topology of GluN subunits. A, 
Amino acid sequence of S1-M1 and S2-M4 linker domains of GluN1 and GluN2 subunits. 
B, Cartoon depicts the broad structural topology of GluN subunits, highlighting the 
locations of the ligand binding domain-forming S1/S2 domains, transmembrane (TM) 
domains, and the S1-M1/S2-M4 linker domains. C-D, Structural models showing the 
relative locations of cysteine-substituted residues of inter- and intra-subunit crosslinked 
GluN2B- (C) and GluN2A-containing (D) receptors. MacPymol (The PyMOL Molecular 
Graphics System, Version 1.5.0.4 Schrödinger, LLC) was used to render structures of 
GluN1/GluN2B (PDB ID: 4PE5; Karakas and Furukawa, 2014) and a homology model of 
the GluN1/GluN2A receptor described in a previous study (Xu et al., 2012) that was based 









Intra-subunit GluN1 S1-M1/S2-M4 linker crosslinking decreases ethanol 
sensitivity of GluN2A- and GluN2B-containing NMDA receptors 
Figure II.2.A shows the amino acid sequence of S1-M1 and S2-M4 linkers 
of GluN1, GluN2A and GluN2B subunits and schematic (Fig. II.2.B) and 
molecular (Fig. II.2.C/D) models of these regions. Results from previous studies 
show that NMDA receptors crosslinked via S1-M1/S2-M4 substituted cysteines 
show marked reductions in open probability and mean open time of 
GluN1/GluN2A NMDA receptors (Kazi et al., 2013) that resemble effects in wild 
type receptors treated with ethanol (Wright, Peoples, & Weight, 1996). On this 
basis, we hypothesized that linker crosslinking would occlude ethanol inhibition of 
NMDARs. As shown in Figure II.3.A, intra-subunit crosslinking of GluN1 
peripheral linkers caused a modest but significant decrease in ethanol sensitivity 
compared to GluN1/GluN2A wild type that was not observed with inter- or intra-
subunit GluN2A linker crosslinking (two-way ANOVA with Dunnett's test; effect of 
mutation, F3,87 = 5.002, p = 0.003; effect of ethanol treatment, F2,87 = 297.6, p < 
0.0001; interaction, F6,87 = 0.282, p = 0.944; N = 6-10 cells). A similar subunit-
Figure II.3: Concentration-dependent inhibition of crosslinked receptors by ethanol. A, Intra-
GluN1 crosslinked GluN2A receptors showed a significant reduction in ethanol sensitivity 
compared to GluN1/GluN2A wild type receptors. Bar graph shows mean ± S.E.M. inhibition of 
agonist-evoked currents by 30, 100, and 300 mM doses of ethanol (* p < 0.05; two-way 
ANOVA with Dunnett’s test; effect of mutation, F3,87 = 5.002; N = 6-10 cells). B, 
Representative trace showing current inhibition by 300 mM ethanol of a GluN1/GluN2A wild 
type NMDAR. C, Similar to results observed in GluN1/GluN2A receptors, only intra-GluN1 
crosslinked GluN2B receptors showed a significant reduction in ethanol sensitivity compared 
to GluN1/GluN2B wild type receptors. Bar graph shows mean ± S.E.M. inhibition of agonist-
evoked currents by 30, 100, and 300 mM doses of ethanol (* p < 0.05; two-way ANOVA with 
Dunnett’s test; effect of mutation, F3,93 = 7.232; N = 7-10 cells). D, Representative trace 




specific effect was observed with GluN2B-containing NMDARs (Figure II.3.C), as 
only intra-subunit GluN1 linker crosslinked GluN1/GluN2B receptors showed a 
significant reduction in ethanol sensitivity (two-way ANOVA with Dunnett's test; 
effect of mutation, F3,93 = 7.232, p = 0.0002; effect of ethanol treatment, F2,93 = 
381.6, p < 0.0001; interaction, F6,93 = 2.918, p = 0.0499; N = 7-10 cells). As a 
control, the sensitivity of single intra-subunit GluN1 cysteine substitutions at S549 
or F810 to 100 mM ethanol was tested, and no change was observed in either 
GluN2A- or GluN2B-containing receptors (GluN1/GluN2A wild type = 45.8%, 
GluN1 S549C/GluN2A = 42.8%, GluN1 F810C/GluN2A = 51.4%; ANOVA; F2,25 = 
3.066, p > 0.05; N = 6-10 cells: GluN1/GluN2B wild type = 55.9%, GluN1 
S549C/GluN2B = 52.1%, GluN1 F810C/GluN2B = 51.5%; ANOVA; F2,25 = 0.377, 
p > 0.05; N = 6-10 cells: values reflect percent inhibition). Note that in the present 
study, the wild-type GluN1/GluN2A receptors show a modest but reliable 
potentiation by DTT not observed with GluN1/GluN2B receptors. This is similar to 
that reported by others and is likely due to relief of tonic zinc inhibition as DTT is 
an effective chelator of zinc (Kohr et al., 1994). The subunit-dependent effect of 
DTT on wild-type receptor currents is consistent with the finding that GluN2A-
containing, but not GluN2B, receptors are highly sensitive to low nanomolar 






Figure II.4: Crosslinking M1 and M4 linker domains of GluN1/2A receptors alters receptor 
function. A, Mean current amplitude of GluN1/GluN2A wild type, intra-, and inter-subunit 
crosslinked receptors in response to 10 uM glutamate/glycine. Bar graph shows mean amplitude 
± S.E.M. of WT and mutant receptors from 6-10 cells(** p < 0.001, *** p < 0.0005; one-way 
ANOVA with Dunnett’s test). B, DTT treatment enhances steady state current amplitude of 
GluN1/GluN2A crosslinked receptors. Bar graph shows mean percent potentiation of current 
amplitude by DTT (10 mM; 20 s) ± S.E.M. from 6-10 cells (# p < 0.05; one-sample t-test: **** p < 
0.0001; one-way ANOVA with Dunnett's test). C, Schematic diagram showing location of 
cysteine-substituted residues in intra- and inter-subunit M1:M4 linker crosslinked GluN1/GluN2A 
receptors. D, Representative trace demonstrating potentiation of intra-GluN2A crosslinked 







Subunit-dependent attenuation of NMDA receptor function via inhibition of S1-
M1/S2-TM4 linker mobility 
Structural modeling and experimental evidence from the Wollmuth 
laboratory shows that the S1-M1 linker of one subunit lies proximal to the 
Figure II.5: Crosslinking M1 and M4 linker domains of GluN1/2B receptors alters receptor 
function. A, Bar graph shows mean amplitude ± S.E.M. of wild type and mutant GluN1/GluN2B 
receptors from 7-10 cells (*** p < 0.0005; one-way ANOVA with Dunnett’s test). B, Effects of 
DTT treatment on intra- and inter-subunit crosslinked GluN1/GluN2B receptors. Bar graph 
shows mean ± S.E.M. percent potentiation of current amplitude by DTT (10 mM; 20 s) from 7-
10 cells (# p < 0.05; one-sample t-test: **** p < 0.0001; one-way ANOVA with Dunnett’s test). 
C, Schematic diagram showing location of cysteine-substituted residues in intra- and inter-
subunit M1:M4 linker crosslinked GluN1/GluN2B receptors. D, Representative trace 





corresponding S2-M4 linker of the other in space, and using this information, we 
selected residues in GluN subunits for cysteine mutation (Sobolevsky, Rosconi, 
& Gouaux, 2009; Karakas & Furukawa, 2014; Kazi et al., 2013). As shown in 
Figure II.4.A, both intra- and inter-subunit crosslinking in GluN2A-containing 
NMDARs produced robust decreases in current amplitude, that was rescued by a 
20 second application of DTT (10 mM) indicating crosslinking of substituted 
cysteines (Figure II.4.B; one-sample t-test; p < 0.05). Interestingly, the degree of 
DTT potentiation of cysteine-substituted GluN2A receptors was greater for intra-
subunit crosslinked receptors (~650%) than for inter-subunit receptors (~375%). 
For GluN2B-containing NMDARs, however, only intra-GluN2B crosslinked 
receptors and inter-subunit GluN1 M4:GluN2B M1 receptors showed an 
appreciable decrease in current amplitude under non-reducing conditions (Figure 
II.5.A). DTT treatment enhanced these currents with the largest DTT-induced 
current potentiation, over 900%, observed for intra-subunit GluN2B receptors 






Figure II.6: Pre-TM4 glycine mutations in GluN1/GluN2A and GluN1/GluN2B receptors alter 
glutamate potency. A, Representative traces from a GluN1/GluN2A-expressing HEK cell 
showing response to 0.1 µM, 3 µM, and 30 µM concentrations of glutamate. B/C, 
Concentration-response curves (B) and summary graph (C) of glutamate EC50 values for 
GluN1/GluN2A wild type and glycine-substituted mutants. Curves shown are best fits to the 
equation  given in Materials and methods. Bar graph shows mean ± S.E.M. EC50 values for 
glutamate-activated currents in wild type and mutant GluN1/GluN2A receptors. Data for 
GluN2A receptors are from 7-9 cells (* p < 0.05; one-way ANOVA with Dunnett’s test). D, 
Representative traces from a GluN1/GluN2B-expressing cell showing response to 0.03 µM, 1 
µM, and 10 µM concentrations of glutamate. E/F, Concentration-response curves (E) and 
summary graph (F) of glutamate EC50 values for GluN1/GluN2B wild type and glycine-
substituted mutants. Curves shown are best fits to the equation  given in Materials and 
methods. Bar graph shows mean ± S.E.M. EC50 values for glutamate-activated currents in 
wild type and mutant GluN1/GluN2B receptors. Data for GluN2B receptors are from 7-9 cells 






Pre-TM4 residues of GluN1 and GluN2 regulate receptor function in a subunit-
dependent manner 
The results shown in Figures II.4 and II.5 and work by others show that 
restricting S2-M4 extracellular linker domain movement by disulfide crosslinking 
significantly attenuates channel gating and function in GluN2A-containing 
NMDARs (Kazi et al., 2013). To determine what effect increasing the flexibility of 
this region has on channel activity, select residues in the Pre-TM4 region, the 
terminal end of the S2-M4 linker before TM4, were mutated to the rotationally 
Figure II.7: Changes in glutamate 
potency in response to mutation 
of Pre-TM4 GluN2B residues. A, 
Substitution of serine (S) 811 of 
GluN2B with an alanine (A) or 
aspartate (D) did not significantly 
change glutamate potency, while 
mutation of the preceding S810 
residue to a glycine produced a 
significant leftward shift in 
glutamate potency. For 
comparison, the effect of GluN2B 
(S811G) on glutamate potency 
(data from Figure 5) is 
represented by the dashed line. 
Data shown are mean EC50 
values ± S.E.M. derived from 
individual curve fits of 5-10 cells 
using the equation given in 
Materials and Methods (*** p < 
0.001; one-way ANOVA and 
Dunnett’s test). B, Substitution of 
glycine at analogous positions in 
GluN1 did not alter glutamate 
potency, while glutamate EC50 of 
GluN2B (S810G) mutant was not 
affected by also substituting a 
glycine at position 811. Data 
shown are mean ± S.E.M. EC50 
values derived from individual 
curve fits of 5-10 cells using the 
equation given in Materials and 
Methods (* p < 0.05; one-way 






active glycine residue. As seen in Figure II.6, robust changes in glutamate 
potency were observed in glycine-substituted mutants and these effects were 
subunit-dependent. Specifically, substitution of alanine 804 to glycine (A804G) in 
the Pre-TM4 of GluN1 produced a small but significant rightward shift in 
glutamate potency in GluN2A-containing NMDARs that was not observed with a 
mutation at the analogous serine 810 (S810G) in GluN2A (Figure II.6.B/C). This 
effect persisted when GluN1 (A804G) was co-expressed with GluN2A (S810G) 
(EC50 values: GluN1/GluN2A wild type = 2.18 µM, GluN1 A804G/GluN2A = 3.69 
µM, GluN1/GluN2A S810G = 2.72 µM, GluN1 A804G/GluN2A S810G = 3.54 µM; 
ANOVA and Dunnett's post test; F3,25 = 4.007, p < 0.05; N = 7-8 cells). For 
GluN2B-containing NMDARs, however, mutation of serine 811 to glycine 
(S811G) produced a profound leftward shift in glutamate potency (Figure II.6.E/F) 
that was not observed in GluN1 (A804G)/GluN2B receptors. This change in 
glutamate potency was eliminated by co-expression of GluN1 (A804G) (EC50 
values: GluN1/GluN2B wild type = 0.90 µM, GluN1 A804G/GluN2B = 1.09 µM, 
GluN1/GluN2B S811G = 0.12 µM, GluN1 A804G/GluN2B S811G = 0.78 µM; 
ANOVA and Dunnett's post test; F8,67 = 9.019, p < 0.0001; N = 7-10 cells). These 
effects were specific for glycine substitutions, as mutation of GluN2B S811 to 
either an alanine (A) or aspartate (D) did not significantly change glutamate 
potency (Figure II.7.A). Furthermore, substitution at adjacent residues in GluN1 
(A803, A804) did not significantly affect the glutamate EC50 value and adding a 
second glycine residue at S810 in GluN2B did not further enhance glutamate 




substitutions on channel function, we used the rate of MK-801 inhibition as an 
index of channel open probability (Chen et al., 1999; Hansen et al., 2013). As 
shown in Table II.2, there were no significant differences in the rate of MK801 
block for any of the glycine mutants tested. Table II.1 summarizes the functional 
characteristics of GluN2A- and GluN2B-containing wild type and glycine-
substituted NMDARs and shows values for mean peak and steady state current 






Subunit-dependent changes in ethanol sensitivity of Pre-TM4 glycine-
substituents 
Results from studies carried out by our laboratory and others have shown 
that a number of sites within the TM3 and TM4 domains of GluN subunits 
influence the ethanol sensitivity of NMDARs (Ronald, Mirshahi, & Woodward, 
2001; Ren, Honse, & Peoples, 2003; Xu, Smothers & Woodward, 2012). To 
examine whether glycine mutations in nearby Pre-TM domains also affect 
ethanol inhibition, we determined the ethanol sensitivity of wild type and glycine-
substituted receptors. As shown in Figure II.8.A/B, while all wild type and glycine-
Figure II.8: Concentration-
dependent inhibition of glycine-
substituted receptors by 
ethanol. A, GluN2A (S810G) 
mutant showed a significant 
reduction in ethanol sensitivity 
compared to wild type GluN2A. 
Data shown are mean ± S.E.M. 
inhibition of agonist-evoked 
currents across three ethanol 
doses (* p < 0.05; two-way 
ANOVA with Dunnett’s test, 
effect of mutation, F2,63 = 5.91, 
N = 7-10 per group). B, In 
contrast to GluN1/GluN2A 
receptors, GluN1 
(A804G)/GluN2B significantly 
increased ethanol sensitivity, 
with no change observed in 
GluN2B (S811G) mutants. Data 
shown are mean ± S.E.M. 
inhibition of agonist-evoked 
currents across three ethanol 
doses (* p < 0.05; two-way 
ANOVA with Dunnett’s test, 
effect of mutation, F2,90 = 






substituted GluN2A- and GluN2B-containing NMDARs displayed concentration-
dependent inhibition by ethanol, there were subunit-dependent differences in 
ethanol potency. For example, the GluN1/GluN2A (S810G) mutant showed a 
significant reduction in ethanol sensitivity compared to GluN1/GluN2A wild type 
NMDARs while this effect was not observed in GluN1 (A804G)/GluN2A receptors 
(two-way ANOVA with Dunnett's post test; effect of mutation, F2,63 = 5.91, p = 
0.0044; effect of ethanol treatment, F2,63 = 288.0, p < 0.0001; interaction, F4,63 = 
0.1857, p = 0.1857; N = 7-10 cells). In contrast, GluN1 (A804G)/GluN2B 
receptors were significantly more sensitive to ethanol, while inhibition of 
GluN1/GluN2B (S811G) receptors was indistinguishable from that of 
GluN1/GluN2B wild type (two-way ANOVA with Dunnett's post test; effect of 
mutation, F2,90 = 7.517, p = 0.001; effect of ethanol treatment, F2,90 = 262.8, p < 
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-462.66 ± 80.4 
(8) 
0.627 ± 0.073 
(8) 




-453.26 ± 108 
(7) 
0.515 ± 0.07 
(7) 




-412.1 ± 114.1 
(7) 
0.814 ± 0.118 
(7) 












-375.01 ± 52.8 
(22) 
-285.65 ± 44.6 
(22) 
0.749 ± 0.048 
(22) 






0.651 ± 0.108 
(7) 
1.23 ± 0.26 (8) 
GluN2B S811G 
-186.82 ± 47.5 
(10) 
-119.1 ± 17.7 
(10) 
0.813 ± 0.102 
(10) 





-328.48 ± 113 
(7) 
0.391 ± 0.082* 
(7) 
N.D. 
(* denotes statistically significant deviation from wild type; one-way ANOVA with 





















































178% ↑  318.6% ↑  653% ↑  
**** 
4.5% ↑  151% ↑  902% ↑ 
**** 
Δ Ethanol 


























2.2 µM  3.7 µM  
* 
2.7 µM  0.9 µM  1.09 µM  0.12 µM  
**** 
Δ Ethanol 
Sensitivity - - ↓ - ↑ - 
Rate of MK-




2.99  3.62  2.57  1.21  1.23  1.6  
NOTE: Underlined values indicate statistically significant deviations from wild type. (one-
way ANOVA with Dunnett’s post-hoc test; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** 








In the present study we tested whether manipulating the mobility of 
extracellular linker domains involved in regulating NMDA receptor gating and 
function would significantly affect the ethanol sensitivity of the receptor. The 
results show that mutations within these domains cause significant changes in 
receptor gating, glutamate potency, and ethanol sensitivity that are subunit-
dependent. These findings highlight a disparity between the structural homology 
conserved between GluN2A and GluN2B subunits and the vastly divergent 
functional and pharmacological characteristics that each subunit imparts to 
receptor activity. Furthermore, the data suggest that such fundamentally different 
subunit-specific contributions to gating may underlie the intrinsic difference in 
ethanol sensitivity previously observed between GluN2A- and GluN2B-containing 
receptors (Masood et al., 1994; Mirshahi & Woodward, 1995). 
Cysteine substitutions at select sites can elicit spontaneous crosslinking 
and subsequent conformational locking of protein regions and this approach has 
been used to probe the functional role of various domains within NMDARs 
(Talukder & Wollmuth, 2011; Kazi et al., 2013). Work by the Wollmuth laboratory 
used cysteine-substituted receptors that conformationally impeded S1-M1 and 
S2-M4 linker movements, and these studies revealed differential contributions of 
GluN1 and GluN2 linkers to receptor gating (Kazi et al., 2013). Specifically, when 
kinetic data from these receptors were fit to models of NMDA receptor gating 




were predominantly dictated by the GluN2A subunit (Kazi et al., 2013), while 
GluN1 and GluN2 subunits made equal contributions to the final C1-O1 transition 
step (Talukder & Wollmuth, 2011). The results of the DTT experiments in the 
present study are consistent with this conclusion as both GluN2A- and GluN2B-
cysteine-substituted receptors showed enhanced current amplitudes following 
thiol reduction with the highest potentiation observed for intra-GluN2 crosslinked 
receptors. While the modest potentiation observed with intra-GluN1 crosslinked 
receptors may simply be due to an incomplete interaction of the cysteines, this 
seems unlikely based on structural models demonstrating a high degree of 
proximity of the mutated residues (Karakas & Furukawa, 2014; Xu et al., 2012).  
Notably, robust whole-cell currents were obtained from intra-GluN1 
crosslinked GluN2B-containing receptors that showed only slight DTT-
potentiation, while intra-GluN1 crosslinking of GluN2A-containing receptors 
showed significant mean current amplitude reduction with robust recovery by 
DTT treatment. This finding as well as the largely homologous results seen with 
inter-subunit crosslinking between receptor subtypes supports the conclusion 
that GluN2-specific, not GluN1, differences likely account for subunit-dependent 
disparities in DTT potentiation. This conclusion is further supported by the 
change in ethanol inhibition with intra-GluN1 crosslinked receptors that occurred 
regardless of the GluN2 subunit expressed. While studies have demonstrated 
that GluN2A- and GluN2B-containing receptors (Erreger et al., 2005; Amico-




including open probability, mean open time, and glutamate dissociation rate, 
work by the Wollmuth laboratory (Kazi et al., 2013) first discriminated unequal 
contributions of the GluN1 and GluN2 subunits within GluN2A-containing 
NMDARs to receptor gating. Our results thus raise the intriguing possibility that 
intrinsic proportional contributions of GluN1 and GluN2 to gating are themselves 
fundamentally different between GluN2A- and GluN2B-containing NMDARs, and 
could underlie the divergent gating profiles observed between the receptor types. 
As a counterpoint to the crosslinking experiments, we generated S2-M4 
glycine mutants to increase the intrinsic flexibility of this region. Substitution or 
addition of glycine residues within discrete regions of ion channels including the 
NMDAR has been shown to enhance movement and function of these channels 
(Kellenberger et al., 1997; Kazi et al., 2014). When the changes in glutamate 
potency of glycine mutants are compared between receptor subtypes, it becomes 
apparent that glycine substitution reveals fundamental differences in the 
contribution of S2-M4 linkers to channel function that are not fully resolved with 
cysteine crosslinking. As observed with GluN2A-containing receptors, glycine 
substitution in the S2-M4 of GluN2A results in no demonstrable change in 
glutamate potency, while glycine substitution in the S2-M4 of GluN1 produces a 
significant decrease in glutamate potency that persists upon co-expression of a 
glycine-substituted GluN2A. In contrast, glycine substitution in the S2-M4 of 
GluN2B produces a profound increase in glutamate potency that is nullified by 




receptors show no discernable change. At first blush it seems curious that 
changing the intrinsic flexibility of the glycine-binding GluN1 subunit would alter 
the potency of the receptor for glutamate, or in the case of GluN2B (S811G) 
receptors, restore glutamate potency to wild type levels. Others, however, have 
shown that the GluN2 subunit can similarly impact the glycine potency of 
NMDARs in a subunit-dependent manner (Chen et al., 2008) suggesting a 
reciprocal interaction between subunits.  
The observed disparity between the effects of glycine substitution on 
glutamate potency in GluN2A- and GluN2B-containing receptors, when 
considered in light of results from crosslinking experiments, implies non-
homologous, subunit-specific contributions to receptor function. Indeed, studies 
have shown that GluN2A-containing NMDARs exhibit a much higher open 
probability compared to GluN2B-containing receptors (Erreger et al., 2005; 
Gielen et al., 2009; Hansen et al., 2013) and the results of the MK-801 blocking 
experiments in the present study reflect these intrinsic differences. These 
subunit-dependent differences in open probability appear to be attributable, at 
least in part, to interactions between the amino terminal domain (ATD) and ligand 
binding domains (LBD) that affect spontaneous opening and closure of the ligand 
binding cleft in GluN2 subunits (Gielen et al., 2009). The high sequence 
homology of core transmembrane gating elements between the GluN2 subunits 
further supports this ATD-LBD interaction model. Based on these findings, we 




glycine mutants is due to a ceiling effect on gating, in which actions of the ATD 
on activity of the ligand binding domain precludes any mutation-induced 
facilitation of the steps between agonist binding and channel gating. However, 
due to the much lower opening probability of GluN2B NMDARs, possibly 
reflective of subunit differences in ATD-LBD interactions, facilitating agonist 
activity by increasing the flexibility of the S2-M4 linker profoundly increases 
glutamate potency. In addition, this change is likely not simply due to increased 
spontaneous movement of core gating elements, as there was no change in the 
rate of MK-801 block in glycine-substituted mutants. Indeed, results from the DTT 
experiments support this conclusion as intra-GluN2B crosslinked receptors 
showed a significantly larger potentiation of current over intra-GluN1 crosslinked 
GluN2B receptors compared to GluN2A-containing receptors. Thus, we conclude 
that mechanistically, the S2-M4 region acts as a significant element in 
transduction of agonist binding to channel gating in GluN2A- and GluN2B-
containing NMDARs and that manipulation of the flexibility of this region reveals 
a substantially higher contribution to channel gating of the GluN2 subunit in 
GluN2B-containing NMDARs compared to GluN2A-containing NMDARs. 
The primary goal of the present study was to determine if manipulation of 
S2-M4 linker flexibility would elucidate mechanisms of ethanol action on NMDAR 
function distinct from core transmembrane sites. While others have shown that 
GluN1 M3/GluN2 M4 residue interactions are non-homologous to GluN1 




hypothesis underlying this study nevertheless initially rested on the assumption 
that the mechanisms of gating between GluN2A- and GluN2B-containing 
receptors were largely homologous. The functional data presented, though, 
argue against this assumption and indeed results from the ethanol experiments 
further support this conclusion. Specifically, a significant decrease in ethanol 
sensitivity was observed in GluN2A (S810G) receptors but not GluN1 
(A804G)/GluN2A receptors. The opposite was observed with GluN2B-containing 
receptors, though, as a significant increase in ethanol sensitivity was observed 
only with GluN1 (A804G)/GluN2B receptors. As the amino acid sequence of the 
S2-M4 is identical between GluN2A and GluN2B subunits, it was predicted that 
either constraining (via cysteine-substitution) or enhancing (via glycine-
substitution) S2-M4 linker mobility would elicit similar effects on ethanol 
sensitivity of GluN2A- and GluN2B-containing NMDARs. The subunit-dependent 
effects of glycine-substitution on ethanol sensitivity observed in the present study 
agree with emerging findings (Zhao et al., 2015) and suggest that ethanol does 
not impede receptor gating of GluN2A- and GluN2B-containing receptors in a 
homologous manner, perhaps as a consequence of the fundamentally different 
contributions of individual GluN2 subunits to channel activity. In sum, we 
demonstrate, in agreement with others, that extracellular linker domains of GluN 
subunits are significant elements in the transduction cascade between agonist 
binding and pore opening and that differential modulation of the mobility of these 
regions reveal fundamental differences in GluN2 subunit contributions to receptor 




modest, reported herein argue that intrinsic differences in ethanol sensitivity 
between GluN2A- and GluN2B-containing receptors may largely be a 
consequence of essential differences in gating between the receptor types 





Chapter III. Secondary Mechanisms of NMDAR Inhibition by Ethanol 
III.1 Introduction 
 As discussed in Section I, the NMDA receptor is a critical link between 
neuronal excitation and the adaptive processes that drive synaptic strengthening 
and depression. The direction and intensity of NMDAR-mediated synaptic 
alterations is largely a product of what GluN2 subunit-containing NMDARs are 
predominantly activated, with extensive evidence suggesting GluN2B-containing 
receptors exhibit the most robust predilection for inducing neuroadaptive 
responses. Importantly, the NMDA receptor is a primary site of action for the 
inhibitory effects of ethanol, and such inhibition correlates strongly with 
behaviorally relevant doses of alcohol impairing known NMDAR-mediated 
phenomena including learning and memory. While our laboratory and others 
have identified a number of sites within the core membrane-spanning elements 
of the receptor as sites of alcohol action, emerging evidence suggests that inter-
molecular interactions between the receptor and secondary effector proteins 
could also mediate ethanol-induced reductions in NMDAR current. 
 Among these studies are reports of physiologically relevant doses of 
ethanol inducing activity of striatal-enriched protein phosphatase (STEP) that 
appears to interact specifically with GluN2B-containing NMDARs and promotes 
internalization of the receptor complex (Alvestad et al., 2003; Wu et al., 2010; 
Hicklin et al., 2011). This schema is based on work previously showing that 




clathrin-mediated internalization of the receptor complex based on 
phosphorylation state (Roche et al., 2001; Prybylowski et al., 2005). In Hicklin et 
al. (2011) the authors observed a consistent reduction in phosphorylation of 
residue Y1472 on GluN2B with ethanol treatment that correlated with receptor 
internalization and STEP activity. Importantly, the authors showed that with 
knockdown of STEP protein, cultured neurons displayed ethanol resistance as 
well as curtailed GluN2B-containing NMDAR internalization. Indeed, when 
considered with data correlating heightened GluN2B-containing NMDAR surface 
expression with ethanol resistance, such a mechanism of sustained ethanol 
inhibition of NMDAR-mediated currents becomes viable (Wang et al., 2007). 
 While attractive, it nevertheless remains unclear as to whether such 
differential phosphorylation of C-terminal tyrosine residues on GluN2B contribute 
to ethanol sensitivity strictly via receptor internalization or if the phospho-state of 
these residues can directly impact receptor function. Initial studies seeking to 
understand the effect of phosphorylation on AMPAR currents seemed to show 
that post translational modification of C-terminal amino acids could regulate 
receptor function directly (Raymond et al., 1993). Indeed, later work with the 
NMDA receptor appeared to show that differential phosphorylation of single 
residues within the C-termini of GluN2 subunits was sufficient to alter ion 
permeability and receptor desensitization at the single channel level (Murphy et 
al., 2014; Aman et al., 2014). Thus, in the present study we sought to determine 




previously shown to be robust sites of STEP activity could alter the intrinsic 
ethanol sensitivity and receptor function of recombinantly expressed NMDARs. If 
dephosphorylation of these tyrosines represents a key step in the inhibition of 
channel currents by alcohol, then rendering these sites permanently 
dephosphorylated should mimic ethanol inhibition and occlude any further action 
of ethanol.   
III.2 Methods 
Cell Culture and Transfection 
Human embryonic kidney (HEK) 293 cells were obtained from ATCC 
(Manassas, VA) and maintained in 10 cm culture dishes containing serum-
supplemented DMEM in a humidified incubator with 5% CO2. Cells were split 
every 48 hours. For recordings, cells were split on poly-ornithine coated 35 mm 
dishes and 24 hours later transfected using Lipofectamine 2000 reagent 
(Invitrogen Inc, Carlsbad, CA). Plasmids containing rat GluN1, wild-type or 
mutant rat GluN2B, and an enhanced green fluorescent protein for cell selection 
were transfected at a 2:2:1 ratio unless otherwise noted. Mutant receptors were 
generated using the Quik Change II site-directed mutagenesis kit (Agilent 
Technologies, Santa Clara, CA) and nucleotide substitutions were verified via 
sequencing (Genewiz, South Plainfield, NJ). Prior to transfection, media was 
exchanged with fresh serum-supplemented DMEM containing 0.5 mM AP5 to 
prevent glutamate-mediated excitotoxicity (Cik et al., 1994).  AP5 was removed 





Dishes containing transfected cells were mounted on an Olympus IX50 
inverted microscope and perfused with an extracellular recording solution at a 
rate of 1-2mL/min. Extracellular recording solution contained the following (in 
mM); NaCl (135), KCl (5.4), CaCl2 (1.8), HEPES (5), glucose (10), (pH adjusted 
to 7.4 with 1M NaOH, and osmolarity adjusted to 315-325 mOsm with sucrose). 
Patch pipettes (2-4 MOhms) were pulled from standard wall borosilicate glass 
(1.5 x 0.85 mm) and filled with internal solution containing the following (in mM); 
CsCl (140), MgCl2 (2), EGTA (5), HEPES (10), NaATP (2), NaGTP (0.3), (pH 
adjusted to 7.2 with 2M CsOH, and osmolarity adjusted to 290-295 mOsm with 
sucrose). Transfected cells were identified by eGFP fluorescence and whole-cell 
voltage clamp recordings were performed at room temperature using an Axon 
Instruments 200B microamplifier (Molecular Devices, Union City, CA). Cells were 
held at -70 mV to monitor breakthrough and maintained at this potential unless 
otherwise noted. Whole-cell capacitance and series resistance were 
compensated for and access resistance was monitored throughout the 
experiment. Cells demonstrating unstable holding currents or significant changes 
in series resistance were excluded from analysis. NMDA currents were evoked 
using a Warner FastStep multi-barrel perfusion system programmed to switch 
between extracellular recording solution and solution containing agonist (10 µM 
glutamate and glycine) or agonist plus ethanol (10-600 mM). Glutamate dose-




concentration of glutamate from 0.03-10 µM. The order of solutions was 
interleaved to monitor current rundown and changes >15% were excluded from 
analysis. For current-voltage relationship experiments, stable whole-cell 
configurations were first established at -70 mV, after which cells were held at 0 
mV. Extracellular solution containing agonist and MgCl2 was then washed on and 
the cell was subjected to a ramp protocol consisting of a jump to -80 mV, a 1.3 
sec ramp to +80 mV, and a return to 0 mV holding potential.  This protocol was 
repeated three times and I-V curves were obtained from the average of the three 
traces. All data were filtered at 1-2 kHz and acquired at 5 kHz using an Instrutech 
ITC-16 digital interface (HEKA Instruments, Bellmore, NY) and analyzed offline 
by Axograph X software (Axograph Scientific, Sydney, NSW, Australia). 
Data Analysis 
Data are expressed as mean ± SEM and were analyzed by analysis of 
variance using Prism 5.0 software (Graphpad Software, San Diego, CA) where 
indicated. Concentration-response curves for ethanol and glutamate were 
analyzed using non-linear regression. Not all ethanol concentrations could be 
tested on each cell thus preventing using Prism to calculate individual IC50s for 
each cell. Instead for these data, a two-parameter (slope and EC50) logistic 
function was estimated for all curves using SPSS (IBM Corporation, Armonk, NY) 
and individual curve IC50s were then analyzed for group differences via ANOVA. 




each group were estimated simultaneously with shared logistic slopes. For all 




Figure III.1 shows a schematic of the GluN2B subunit, highlighting the N-
terminal domain, the glutamate binding site, transmembrane domains, and the 
intracellular C-terminal region of the GluN2B subunit. Residues that were 
mutated from tyrosine to phenylalanine were at positions 1252, 1336 and 1472 of 
Figure III.1: Schematic cartoon of the NMDA GluN2B subunit. The extracellular N-terminus, 
four transmembrane domains denoted by the four blue boxes, and the intracellular C-terminus 
are depicted in the diagram. Red circles on the intracellular C-terminus indicate the 
approximate location of tyrosine residues 1252, 1336, and 1472. Also depicted are 





the full length rat GluN2B subunit. Wild-type and mutant GluN2B constructs were 
co-expressed with GluN1-1a subunits in HEK293 cells and whole-cell patch 
clamp electrophysiology was used to determine the sensitivity of ethanol.  
 
Table III.1 summarizes the functional characteristics of wild-type and 
mutant receptors in terms of peak and steady-state amplitude and the steady-
state to peak ratio, a marker of macroscopic receptor desensitization. While no 
significant differences were observed between wild-type and mutant receptors for 
peak current amplitude, one-way ANOVA revealed an overall significant effect 
between groups for steady-state current amplitude and steady-state to peak ratio 
(f(4,119)=2.2694, p=0.034; f(4,119)=2.729, p=0.032 respectively). Post-hoc 








To determine whether manipulation of the three tyrosine residues altered 
the receptor’s affinity for agonist, concentration-response curves for glutamate 
were generated. As shown in Figure III.2, increasing concentrations of glutamate 
evoked increases in whole-cell current in both wild-type and mutant receptors. 
Nonlinear regression analysis revealed no significant difference in glutamate 
affinity for any of the mutants tested. Calculated EC50 values for glutamate were 
Figure III.2: Concentration-response relationship for glutamate activation of mutant and wild-
type GluN2B-containing NMDARs. (A) Example traces showing currents from wild-type 
NMDAR transfected cell during exposure to to 0.03 μM (black), 1 μM (light blue), and 10 μM 
glutamate (dark blue). (N = 6 - 8 cells). All recordings performed in the presence of 10 µM 
glycine. (B) Currents are expressed as percent of maximal response to various concentrations 
of glutamate (0.03-10 μM). Non-linear regression yielded EC50 values of 0.92 μM (wild-type), 
0.88 μM (Y1472F), 0.95 μM (Y1336F), 0.78 μM (Y1252F), and 0.69 μM (triple mutant). Inset 





0.92 μM (wild-type), 0.88 μM (Y1472F), 0.95 μM (Y1336F), 0.78 μM (Y1252F), 
and 0.69 μM (triple mutant). ANOVA revealed no significant differences between 
groups for glutamate EC50 values (f(4,27)=0.822, p=0.523). 
 
 
As a follow-up to the agonist dose-response experiments, the effect of 
tyrosine mutations on the voltage-dependent magnesium block of NMDA 
receptors was also determined. Figure III.3.A shows glutamate-evoked currents 
Figure III.3: Current-voltage relationship of wild-type and phospho-mutant NMDARs. (A) Cells 
were voltage clamped at 0 mV and then stepped to -80 mV for 200 ms followed by a 1.3s 
ramp to +80 mV for another 200 ms before returning to 0 mV. All recordings were performed 
in the presence of 2 mM Mg++. (N = 7 – 9 cells) (B) Current-voltage relationship of wild-type 






in the presence of 2 mM Mg++ in cells held at different membrane potentials.  In 
these studies, the concentrations of glutamate and glycine were held at 10 µM 
and current amplitude was expressed as a function of cell capacitance. Analysis 
of the current-voltage relationship revealed no significant differences between 
wild-type and mutants receptors although overall amplitudes did tend to vary. To 
account for this variability, I/V curves generated in each cell were normalized to 
the amplitude measured at +80 mV where Mg block is minimal. Figure III.3.B 
shows these normalized data and confirms there were no differences in voltage-
dependent block between wild-type and mutant receptors.  
 
 
Figure III.4: Concentration-response effect of ethanol on wild-type and mutant GluN2B-
containing NMDARs. (A) Example traces from a cell expressing wild-type and mutant GluN2B 
receptors. Agonist-only (blue) current; agonist + 100 mM EtOH (black). (B) Data are 
expressed as percent inhibition by ethanol (10-600 mM) of glutamate-evoked currents. (N = 6 
– 8 cells per concentration). Non-linear regression yielded estimated IC50 values for ethanol of 
136 mM (wild-type), 135 mM (Y1472F), 118 mM (Y1336F), 104 mM (Y1252F), and 156 mM 








Finally, the effect of a series of ethanol concentrations on glutamate-
activated currents was determined for wild-type and mutant receptors. In these 
studies, currents were evoked with 10 µM glutamate/glycine in the absence or 
presence of ethanol (10-600 mM). As shown in Figure III.4, ethanol caused a 
concentration-dependent inhibition of wild-type and mutant receptors. At the 
lowest concentration tested (10 mM), currents were inhibited by approximately 5-
15% while 600 mM ethanol completely eliminated NMDA receptor currents. In 
fact, in all receptors tested, 600 mM ethanol resulted in slightly greater than 
100% inhibition due to the presence of outward currents at this concentration. 
These currents may have resulted from ethanol’s inhibition of leak current or from 
the slight change in ionic strength (~4%) produced when preparing the 600 mM 
ethanol solution. To examine these possibilities, non-transfected cells were 
voltage-clamped at -70 mV and holding currents were monitored before and 
during administration of ethanol. At a concentration of 600 mM, ethanol produced 
outward currents in non-transfected cells with an average amplitude of 11.63 pA 
± 5.25 pA (mean ± SEM). No such effect was observed when ethanol was 
replaced with water suggesting that ethanol’s effect on holding current was due 
to inhibition of a leak current and not a change in ionic strength. To account for 
this effect, the mean amplitude of the outward current measured in non-
transfected cells was subtracted from the currents obtained in transfected cells 
during exposure to 600 mM ethanol. Regression analysis of the ethanol 
concentration-response curves yielded estimated IC50 values of 136 mM for wild-




mM for the triple mutant. There were no significant differences between groups 
for ethanol IC50 (f(4,86)=1.48, p=0.215). 
III.4 Discussion 
In the present study, site-directed mutagenesis and whole-cell patch-
clamp electrophysiology were used to examine the ethanol sensitivity of 
recombinant NMDARs with mutations that mimic permanently dephosphorylated 
tyrosine residues implicated in the inhibitory actions of ethanol. All mutant 
receptors tested in HEK293 cells showed robust glutamate-activated currents 
and all mutants retained wild-type like sensitivity to ethanol. The results of this 
study strongly suggest that dephosphorylation of these C-terminal tyrosine 
residues does not mediate the acute inhibitory actions of ethanol on recombinant 
NMDARs. They also suggest that ethanol inhibition of NMDA receptors 
expressed in native neurons is not solely due to dephosphorylation at these sites 
as has been suggested from studies in brain slices (Wu et al., 2010; Hicklin et al., 
2011). Indeed, it is more likely that the phosphorylation state of these residues 
may represent intermediate sites of regulation in a larger cascade of events that 
are induced during long exposures to ethanol.   
NMDA receptors are subject to tyrosine phosphorylation and the Src-
family kinase Fyn is highly enriched in neurons where it associates with GluN2B-
containing NMDARs. Over-expression of a constitutively active form of Fyn 
kinase in cerebellar granule cells resulted in robust increases in NMDA mini-




insertion of NMDARs (Prybylowski et al., 2005). Co-expression of Fyn kinase 
with recombinant NMDA receptors to enhance tyrosine phosphorylation had no 
effect on the ethanol sensitivity of GluN1/GluN2B currents, supporting the 
hypothesis that changes in NMDAR currents observed in neuronal tissue by Fyn 
is due to altered trafficking (Kohr and Seeburg, 1996; Anders et al., 1999). Work 
conducted by Nakazawa et al. (2001) further showed that Fyn preferentially 
phosphorylates residues Y1252, Y1336, and Y1472 on GluN2B. 
The interaction of Fyn kinase with GluN2B receptors is highly brain region 
dependent. Work by Yaka et al. (2003) showed that compartmentalization of Fyn 
with NMDARs occurs prominently in hippocampus and dorsal striatum but not in 
cerebral cortex. This interaction requires the scaffolding protein RACK1 and 
enhanced scaffolding of Fyn and GluN2B via RACK1 during ethanol exposure 
allows for increased membrane insertion of GluN2B-containing NMDARs, 
resulting in enhanced currents and the development of a functional form of acute 
ethanol tolerance (Wang et al., 2007; Wang et al., 2010). This mechanism is 
consistent with the lack of acute ethanol tolerance at the electrophysiological and 
behavioral level observed in Fyn-deficient mice (Miyakawa et al., 1997).  
While activation of Fyn and enhanced NMDAR membrane trafficking may 
compensate for reduced NMDA signaling during acute ethanol inhibition,  recent 
data from other laboratories suggests that dephosphorylation of key GluN2B 
tyrosine residues by striatal enriched protein phosphatase (STEP) may directly 




striatum and hippocampus, and associates with GluN2B-containing NMDARs 
(Pelkey et al., 2002). It has been hypothesized that STEP mediates the inhibitory 
actions of ethanol on NMDARs by dephosphorylating Y1472 on the C-terminus of 
GluN2B. Using a phospho-Y1472 GluN2B antibody, Wu et al. (2010) 
demonstrated a significant reduction in immunoreactivity in hippocampal slices 
following acute administration of 80 mM ethanol. Further work showed that mice 
lacking STEP showed no change in the phosphorylation of Y1472 following 
ethanol administration (Hicklin et al., 2011). Inhibiting STEP with dominant-
negative peptide eliminated ethanol inhibition of NMDAR-mediated EPSCs in 
hippocampal slices. Interestingly, however, a compensatory rebound in NMDAR 
current was observed after washout of ethanol in these experiments, likely due to 
the activity of Fyn (Yaka et al., 2003). 
In the present study, mutating Y1472 to phenylalanine in order to mimic a 
permanently dephosphorylated state had no effect on ethanol sensitivity or 
channel function of recombinant GluN2B receptors. These results are consistent 
with prior work by our laboratory that found co-expression of various kinases 
including c-Src and Fyn also had no effect on the ethanol sensitivity of 
recombinant GluN2B-containing NMDARs, despite significant enhancement of 
tyrosine phosphorylation of these subunits (Anders et al., 1998; Anders et al., 
1999). Results from recombinant and brain slice studies instead suggest that 
acute administration of ethanol likely induces multiple effects. First, ethanol 




interacting with regions of GluN1 and GluN2 subunits that are involved in 
receptor gating (Ren et al., 2012; Ronald et al., 2001; Smothers and Woodward, 
2006; Xu et al., 2011). Next, via an unknown mechanism, STEP is activated and 
preferentially recruited to GluN2B subunits where it dephosphorylates Y1472, 
promoting their removal from the post-synaptic density and internalization 
(Hicklin et al., 2011; Prybylowksi et al., 2005). Finally, ethanol-induced activity of 
Fyn via Rack1 scaffolding compensates for STEP-induced internalization, 
producing enhanced surface expression of NMDARs that is revealed following 
ethanol washout (Wang et al., 2007). Such a scenario may exist in brain regions 
such as hippocampus and striatum where STEP and Fyn prominently associate 
with GluN2B-containing NMDARs. Other brain areas such as cortex that do not 
show robust interactions with STEP and Fyn show significant inhibition of NMDA-
mediated EPSCs without evidence of a rebound in NMDA EPSCs following 
cessation of ethanol exposure. 
In summary, the results of this study show that the phospho-state of key 
C-terminal tyrosine residues of the GluN2B subunit does not directly regulate 
ethanol sensitivity. Rather, these residues likely influence apparent ethanol 
sensitivity via alterations in the trafficking and surface expression of GluN2B-
containing NMDARs. Such data demonstrate that the actions of ethanol are 





Chapter IV: Mechanisms of Triheteromeric GluN1/GluN2A/GluN2B NMDA 
Receptor Regulation 
IV.1 Introduction 
 As discussed in previous sections, NMDA receptors can exhibit vastly 
different kinetic profiles as well as highly idiosyncratic intermolecular signaling 
cascades depending on the GluN2 subunit subtype being studied. Due largely to 
the high fidelity of many subtype-specific pharmacological agents such as 
ifendprodil and TCN-201, much of the work teasing out the role of different 
NMDA receptor subtypes in neuronal function has necessarily probed “pure” 
diheteromeric populations. In these studies, receptors are composed of two 
obligate GluN1 subunits and two copies of the same GluN2 subtype (e.g. 2A) 
arranged in a 1:2:1:2 orientation. However, evidence including that from early 
studies of NMDA receptor expression has suggested that triheteromeric NMDA 
receptors containing two different GluN2 subunits exist and may even 
predominate in some brain areas (Wafford et al., 1993; Dunah et al., 1996). 
Indeed, by exploiting intrinsic receptor properties such as differential magnesium 
sensitivity between GluN2A- and GluN2B-containing NMDARs in tandem with 
sub-maximal concentrations of subtype specific antagonists, researchers have 
parsed out unique pharmacological and kinetic profiles of triheteromeric 
NMDARs that appear to better model the NMDA-dependent signaling dynamics 





While the method described above has proven effective at generally 
probing the idiosyncratic nature of triheteromeric NMDARs, “cleanly” isolating a 
population of triheteromers for study, even in recombinant expression systems, 
has remained a challenge. Recently, however, two research groups working 
independently established a method that took advantage of the complementary 
retention motifs on GABAB1 and GABAB2 subunits that drive dimerization of 
native GABA-B receptors. These motifs were cloned onto the ends of cDNAs 
encoding GluN2A and GluN2B in order to bias expression of a triheteromeric 
GluN1/GluN2A/GluN2B receptor conformation in oocytes (Terunuma, Pangalos, 
& Moss, 2010; Hansen et al., 2014; Stroebel et al., 2014). Exploitation of this 
phenomenon has not only confirmed the unique signaling characteristics of 
triheteromeric NMDARs observed by Rauner and Kohr (2011), but has enabled 
researchers to now study the effects of a vast array of pharmacological agents, 
on this heretofore neglected receptor population. As outlined in Section II, 
assumptions of congruent action of alcohol on different GluN2-containing 
receptors have proven untenable, suggesting the intriguing possibility that 
ethanol could exhibit substantially different actions on triheteromeric NMDARs 
both at the level of channel function as well as the novel signaling cascades 
these receptors may govern. 
At the most basic level, though, significant questions remain regarding the 
intrinsic regulation of these novel receptors. Specifically, it remains unknown 




receptors at the synapse. While the process of diheteromer vs. triheteromer 
sorting could be stochastic and simply driven by cell-specific differences in 
subunit expression, experiments have shown that the magnitude of the surface 
expression of GluN3-containing NMDARs is critically dependent on what GluN1 
splice variant is present (Smothers & Woodward, 2009). Indeed, GluN1 splice 
variants are determined primarily by alternating inclusion/exclusion of C-terminal 
cassettes averages ~20 amino acids in length that contain differential retention 
motifs and can affect intrinsic channel properties such as receptor desensitization 
and calcium permeability (Traynelis et al., 2010). GluN1 subunits are further 
discriminated as “A” or “B” type variants depending on the absence or presence 
of an N-terminal stretch of amino acids, known as Exon 5, and can affect 
receptor complex assembly within the ER (Meddows et al., 2001; Qiu et al., 
2009). 
 
In addition, Clapp et al. (2010) observed a significant upregulation of C2’ 
cassette-containing GluN1 splice variants following chronic ethanol exposure. 
Considering that GluN1 splice variants are defined by the presence or absence 
of differential endoplasmic reticulum retention motifs, this phenomenon implies 
that NMDA receptors undergo directed, GluN1-subtype specific sorting prior to 




insertion into the plasma membrane. Furthermore, data has shown that at the 
level of the endoplasmic reticulum, GluN1 and GluN2 subunits exhibit directed 
assembly, to the extent that only fully complemented tetramers are allowed to 
exit and traffic to the plasma membrane (Riou et al., 2012). Taken together, this 
data and the enriched presence of triheteromers at the synapse suggests that 
triheteromeric NMDA receptors likely exhibit some form of directed sorting prior 
to insertion into the plasma membrane, and that such sorting may be critically 
dependent on the expression of GluN1 splice variants. The profound GluN1 and 
GluN2 subtype-specific expression changes of NMDA receptors by ethanol 
exposure outlined above and in Section I thus suggest triheteromeric NMDA 
receptor populations may be similarly affected. Thus, we hypothesize that altered 
expression of GluN1 splice variants after ethanol exposure represents a 
mechanism for altered triheteromeric NMDAR expression. To test this 
hypothesis, HEK 293 cells were tranfected with cDNAs expressing GluN2A-YFP 
and GluN2B-R.Luciferase (Rluc) along with one of the eight different GluN1 
splice variants. We then used bioluminescence resonance energy transfer 
(BRET) to evaluate the intrinsic association of GluN2A and GluN2B subunits 






Figure IV.1: Figure depicts the experimental basis of BRET. Luciferase from Renilla 
reniformis (Rluc; R) decarboxylates coelenterazine and as a by-product releases light at the 
480 nm wavelength. If Rluc comes into proximity (e.g. within 100 Angstroms) with a 
fluorescent protein like yellow fluorescent protein (YFP; Y), such as in an NMDA receptor 
complex, the photon released by coelenterazine digestion will instead undergo resonance 
energy transfer and be emitted in the longer wavelength YFP emission spectrum. This BRET-
mediated YFP emission can then be quantified and compared between GluN1 splice variant 
expression groups, allowing the experimenter to determine the relative rates of 




IV.2 Methods  
Cell culture and BRET 
 In brief, HEK-293 cells were maintained in 10 cm culture dishes with 10% 
serum-supplemented DMEM in a humidified incubator supplied with 5% CO2 and 
split every other day. Fusion proteins were generated by cloning an enhanced 
yellow fluorescent protein (YFP) cDNA onto the C-terminus of GluN2A and a 
bioluminescent luciferase from Renilla reniformis onto the C-terminus of GluN2B. 
For experiments, cultures were plated onto 6-well plates and transfected with 
GluN1, GluN2A-YFP, and GluN2B-Rluc at a 2:1:1 ratio using Lipofectamine 3000 
(Invitrogen; Carlsbad, CA) reagent. The culture medium was supplemented with 
0.5 mM AP5 (Abcam; Cambridge, MA) to prevent excitotoxic cell death, and 
experiments were performed 24 hours after transfection. Bioluminescence 
resonance energy transfer (BRET) experiments were conducted according to 
procedures outlined in Oner et al. (2010). Briefly, cells were washed once with 1x 
phosphate-buffered saline and harvested with Tyrode’s solution containing (in 
mM): NaCl 140, KCl 5, CaCl2 2, NaH2PO4 0.37, NaHCO3 24, HEPES 10, and 
0.1% glucose (w/v) (pH adjusted to 7.4 with NaOH). Cells were distributed in 
triplicate into gray 96-well optiplates and all fluorescence/luminescence signals 
measured using a TriStar LB 941 plate reader (Berthold Technologies, Oak 
Ridge, TN). The luciferase substrate Coelenterazine H (3 uM final concentration) 
was added for 2 min after which luminescence was measured (donor, 480 ± 20; 




and net BRET values were obtained by subtracting the background signal 
detected from expression of cells expressing the Rluc-tagged construct alone. 
Data analysis 
 Statistical comparisons including one-way and two-way Analysis of 
Variance were conducted using Prism 6.0 (Graphpad Software, Inc., San Diego, 
CA). 
IV.3 Results  
 
 
BRET Reveals GluN1 Splice Variant-Independent Triheteromeric Assembly 
Figure IV.2: Analysis of Net BRET values between GluN2A-YFP and GluN2B-Rluc reveals 
that the presence of GluN1 results in a significant reduction in BRET signal for all variants 
except GluN1-1a. (* = p < 0.001, two-way ANOVA with Bonferroni’s post hot test; interaction 
p < 0.05, F4,100 = 2.725; experimental condition p < 0.001, F4,100 = 5.102; splice variant p < 




 In Figure IV.2, BRET values were compared between GluN1+ and GluN1- 
experimental groups among the different splice variants. With the exception of 
GluN1-1a, all other splice variants including the mutant GluN1-6A exhibited a 
significant decrease in net BRET signal compared to net BRET values of 
observed in the absence of GluN1 expression. As discussed in Stroebel et al. 
(2014), the GluN1-6A mutant has six key C-terminal residues that were mutated 
to alanines, thus nullifying the high fidelity ER retention motifs normally present in 
the wild-type GluN1-1a variant. The reduction in BRET with GluN1-6A and lack of 
such an effect with the wild-type variant thus likely reflects alterations in the 
degree of ER retention between these two variants. The inclusion of a GluN1-
lacking experimental condition (hashed bars in Figure IV.2) stems from work by 
Qiu et al. (2005) showing that GluN2 subunits will spontaneously co-assemble in 
the absence of GluN1 within the ER, and thus provides both an estimate of 
BRET signal generated by GluN1-independent assembly and a control condition 
that different GluN1 subtype expressing groups can be normalized against. From 
this data it is inferred that, while a significant population of triheteromers are likely 
being assembled, diheteromeric populations are assembled as well although to a 
lesser degree. While these results cannot definitively rule out the possibility that 
the decrease in BRET is simply an artifact of higher surface area of the plasma 
membrane relative to the ER resulting in reduced random BRET signal, this is 
unlikely as there is no correlation between signal intensity and expression levels 
of GluN2A-YFP and GluN2B-Rluc (Figure IV.5) and in fact such data argues 




signal may be due to presence of GluN1 driving YFP and Rluc apart, leading to 
an interpretation in which reduction in BRET signal instead implies enhanced 
triheteromerization. This possibility cannot be ruled out with the data presented, 
although co-immunoprecipitation of GluN2A and Western blotting for GluN2B can 







When normalized to GluN1-lacking values, the data appear to show that 
triheteromeric GluN1/GluN2A/GluN2B receptors constitute nearly 75% of the 
receptor pool as shown in Figure IV.3. Importantly, however, triheteromericity 
seems to occur irrespective of GluN1 splice variant type. Furthermore as shown 
in Figure IV.4, expressing the “B” GluN1 variants that contain the N-terminal 
Exon 5, appears to have no effect either on triheteromeric assembly or 
trafficking. Thus, it appears that triheteromeric expression occurs regardless of 
the GluN1 splice variant, although retention motifs within GluN1-1a may help act 
as a preliminary sorting mechanism. 
Figure IV.3: By taking a ratio of GluN1+ to GluN1- net BRET, we see that all splice variants 
except GluN1-1a exhibit a significant decrease in signal likely reflective of reduced 
association of GluN2A-YFP and GluN2B-Rluc as the fully complemented receptors are 
trafficked out of the ER and to the membrane. Indeed, it is inferred that since a reduction in 
signal is observed with the GluN1-6A mutant that significant retention of receptors in the ER 
is occurring with the GluN1-1a variant. (* = p < 0.01; One-way ANOVA with Tukey’s post hoc 





Figure IV.4: The “B” GluN1 variants containing Exon 5, an ~25 amino acid inclusion in 
the N-terminal domain, were also evaluated due to the known role of N-terminal domain 
alignment in receptor complex assembly. Statistical comparison of A and B variant 
GluN1+/GluN1- ratios yielded no significant results suggesting the presence of Exon 5 
does not affect triheteromeric NMDA receptor assembly. (Two-way ANOVA; interaction p 
> 0.05, F2,60 = 3.022; A/B subtype p > 0.05, F1,60 = 0.422; splice variant p < 0.0001, 







As revealed by the BRET data, it appears that splice variants of GluN1 
that possess alternative C-termini do not significantly contribute to triheteromeric 
GluN1/GluN2A/GluN2B assembly within the ER. While reports have shown that 
significant ER retention motifs within the C-termini of GluN1 splice variants can 
Figure IV.5: Linear regression analysis of Acceptor/Donor expression and Net BRET 
signal reveals no significant correlation, indicating that the signal observed is reflective 
of a specific interaction. Furthermore, expression of 2B-Rluc with soluble YFP elicits 






greatly impact surface delivery of NMDA receptors, the presence of the C1 
cassette appears to largely dictate retention of NMDARs as total C-terminal 
truncation does not alter receptor membrane expression (Ehlers et al., 1998; 
Scott et al., 2001; Meddows et al., 2001). Indeed, our data as well as studies 
showing mutation of select residues within the C1 cassette or masking of C1 
retention motifs by additional cassettes effectively relieve ER sequestration 
(Ehlers et al., 1998; Riou et al., 2012). Taken together, this data argues that the 
C-terminal alternative splicing of GluN1 may largely be a mechanism to dictate 
post-assembly targeting of fully complemented receptors, and does not 
significantly participate in GluN1/GluN2 co-assembly.  
 Further work has shown that N-terminal residues may instead be 
essential regulators of GluN1/GluN2 subunit association. While experiments 
have shown that N-terminal regions of GluN1 and GluN2 contain additional ER 
retention motifs, observations that their progressive deletion correlates with both 
blunted surface delivery and heightened presence of GluN1 homodimers argues 
that their presence is essential in the recognition and resulting co-assembly of 
GluN1 and GluN2 (Meddows et al., 2001; Qiu et al., 2009). Strangely, however, 
we did not observe any differences in net BRET between the “A” and “B” variants 
suggesting that such N-terminal recognition between GluN1 and GluN2 occurs 





Thus, while discrete regions within GluN1 appear to be essential in both 
the assembly of complete NMDA receptor complexes as well as the exit of these 
receptor complexes from the endoplasmic reticulum, they do not appear to 
participate in the directed formation of triheteromeric GluN1/GluN2A/GluN2B 
receptors. Given the role of GluN1 and GluN2 C-termini in facilitating interactions 
with synaptic scaffolding proteins such as neuronal filaments and α-actinin, it 
seems much more likely that triheteromeric assembly is a stochastic process, 
and that post-assembly interactions in the secretory pathway govern synaptic 
enrichment of triheteromeric NMDARs (Wyszynski et al., 1997; Ehlers et al., 
1998; Scott et al., 2001; Scott, Blanpied, & Ehlers, 2003). It remains unknown, 
however, if the presence of subtype-specific C-termini of GluN2 subunits can 
either regulate triheteromeric assembly or influence post-assembly trafficking 
distinct from diheteromeric NMDARs, and represents an interesting future 






Chapter V: Discussion 
V.1 Summary of Findings 
 In Section I, the essential role of the N-methyl-D-aspartate receptor in 
neurotransmission was detailed with special emphasis on outlining the 
dichotomous function of NMDAR-mediated activity in synaptic signaling. 
Specifically, the relationship between intrinsic magnesium sensitivity, high 
calcium permeability, and high propensity for calcium-dependent inter-molecular 
signaling of NMDARs were discussed to impress the importance of this receptor 
in a number of synaptic processes including long term potentiation, understood to 
be the molecular basis for learning and memory. Such pains were taken in order 
to demonstrate how the preferential activity of alcohol, its predilection for NMDAR 
antagonism in particular, at this receptor can elicit profound behavioral 
manifestations such as acute intoxication, and that with continued exposure 
compel the induction of pathological behaviors that drive further alcohol abuse. 
 While much is now known both of the role of NMDARs in synaptic 
plasticity as well as the actions of ethanol on NMDA receptor function, gaps in 
knowledge nevertheless remain. One such glaring example is a persistent 
disregard for NMDA receptor subtype in teasing the actions of alcohol both on 
intrinsic receptor function and on NMDAR-dependent inter-molecular 
interactions. Thematically, then, the research I have conducted and presented 




receptors by discriminating them according to subtype, GluN2A- and GluN2B-
containing types in particular. 
 Though the overarching hypothesis of Section II sought to determine what, 
if any, role extracellular linker domains had in dictating intrinsic sensitivity of 
NMDARs to ethanol, a corollary posited that manipulation of these domains could 
reveal essential differences in ethanol sensitivity between GluN2A- and GluN2B-
subtypes. Indeed, while the data presented show that linker domains are not 
major determinants of receptor sensitivity to ethanol, the experimental methods 
employed did reveal essential differences in gating between the GluN2 subtypes 
that do affect the innate sensitivity of the receptor to alcohol. As these results are 
among the first to describe this phenomenon, their significance remains to be 
determined. 
 Section III similarly sought to parse GluN2A- and GluN2B-intrinsic ethanol 
actions by seeking to reveal whether the subunit-specific post-translational 
modifications of GluN2B described in Sections I.9-10 and III.1 could account for 
the differential potencies of ethanol between these subtypes. As previously 
discussed, the dephosphorylation of select tyrosine residues on the distal C-
terminus of GluN2B is correlated with inhibition of NMDAR-mediated current by 
alcohol in neurons, and these sites are not found in homologous positions in 
GluN2A. Mutation of these residues to a non-phosphorylatable phenylalanine 
showed that these sites to do not significantly affect either basic receptor function 




II; namely, that essential differences in channel gating between GluN2A- and 
GluN2B-containing NMDARs dictate their differential sensitivities to ethanol, not 
extraneous, subunit-specific sites of action. 
 Finally, Section IV.1 detailed the accumulating evidence suggesting that 
not only do NMDA receptors exhibit myriad different GluN2 subunit types, but as 
well that different GluN2 subunits heterogeneously assemble within individual 
receptors, adding further complexity to an already diverse receptor pool. Many 
significant questions remain regarding these novel triheteromeric receptors, 
however, we wished to determine whether the obligate GluN1 subunit, and its 
eight potential splice variants, could bias the formation of diheteromeric or 
triheteromeric GluN1/GluN2A/GluN2B receptor types. From the data presented, 
we conclude that such a case is unlikely, and that diheteromer/triheteromer 
receptor sorting occurs at a level beyond initial ER assembly.  
V.2 Future Directions 
 While linker domains do not appear to participate significantly in defining 
the intrinsic sensitivity of NMDA receptors to ethanol, results observed in Section 
II nevertheless reveal new insights into the inherent function of and alcohol action 
on different NMDAR subtypes. That intrinsic differences in channel gating may 
partially define the idiosyncratic sensitivities to ethanol observed between GluN2 
subtypes is especially interesting when considering the fundamentally different 
roles of NMDA receptor types in eliciting plastic phenomena such as long term 




such innate differences in alcohol sensitivity between the subtypes not only is a 
key determinant in driving the GluN2B-centric metaplastic mechanisms detailed 
in Sections I.9-10 and III that occur with chronic alcohol exposure, but as well 
these innate differences participate, if at all, in propagating the hedonic valence 
of alcohol intoxication. With the development of CRISPR-Cas9 technology, 
engineering knock-in mice that can display altered sensitivities of specific GluN2 
subunits could be an invaluable resource to probe these very questions. 
 In a similar vein, it is unclear as to whether the metaplastic events detailed 
in Section III.1 are in any way related to the acute inhibition of NMDAR-mediated 
current by ethanol. Specifically, whether or not the effect of alcohol on NMDAR 
current, modest as it is, alters receptor signaling in such a way as to recruit 
GluN2B/STEP interactions, or if instead induction of STEP is an unrelated, 
upstream process. Again, creating a viable knock-in mouse expressing an 
alcohol insensitive mutant GluN2B subunit would allow for this phenomenon to 
be tested. Recent efforts by our laboratory to do this have so far been 
unsuccessful. 
 In Section IV the intriguing question was posed as to the functional 
significance of novel triheteromeric GluN1/GluN2A/GluN2B NMDA receptors in 
the pathogenesis of alcohol use disorders. Since relatively little is known about 
the function and expression of these receptor populations, reflected by a dearth 
of studies specifically addressing them in the literature, they represent fertile 




on a process distinct from GluN1-directed assembly, more elementary questions 
abound. Indeed, it remains unknown as to whether this receptor population is 
predominantly synaptic or extrasynaptic, much less whether chronic alcohol 
exposure alters their presence on the membrane.  
V.3 Final Thoughts 
 The paramount reason for studying addiction is presumably in the noble 
pursuit of a cure. However, the ever-present lack of a “magic bullet” for alcohol 
use disorders even in the face of the decades of research outlined in Section I 
highlights the monumental difficulty in achieving such a goal. At its root, the 
problem is likely the sum of two factors, one being a research paradigm that has 
placed significant emphasis on small molecule treatments, thereby reducing 
complex cognitive disorders down to single molecules that target single 
receptors. The experimenters are not entirely to blame, as much of addiction 
research funding stems from publically supported institutions that expect extrinsic 
dividends for their support. The other, related factor stymying addiction treatment 
has been the rather slow development of effective non-invasive tools for treating 
cognitive disorders with minimal off-target effects. Indeed, such tools have only 
very recently come to the fore, in the form of transcranial magnetic stimulation 
(TMS) in its many iterations.  
As to the first point, study of organic disorders often begins at the genetic 
or molecular level since many diseases are characterized by high-penetrance 




receptor/protein dysfunction as observed with neurofibrillary tangles and 
aggregated amyloid-β protein that are the hallmarks of Alzheimer’s Disease. 
While most clinicians agree that addiction is an organic disorder, and the NMDA-
mediated metaplastic adaptations discussed in Section III.1 reflect this, the 
pathogenesis of the disease appears to begin at a much higher functional level. 
Indeed, divining the root cause of why people abuse ethanol in the first place 
highlights the intrinsically higher-order cognitive nature of addiction. To be sure, 
profound molecular adaptations are known to occur that proffer the addicted 
state, however targeting the symptoms rarely, if ever, cures the underlying 
disease. Thus, a tenable and lasting treatment for alcohol addiction likely lies in 
the implementation of novel therapies such as TMS whose therapeutic 
mechanisms seek primarily to re-engage and potentiate the activity of atrophied 
regions of executive function such as the dorso-lateral prefrontal cortex and as a 
result re-instill higher-order cognitive control on the patient’s over-represented 
limbic drives. Collaborative pilot studies between the NIAAA and the University of 
Palermo have in fact demonstrated the power of this technique in treating 
cocaine addiction and likely portend a substantial increase in its clinical use 
(Terraneo et al., 2016). 
 This is not to say that molecular pharmacological research has nothing of 
value to offer; quite the contrary. As outlined in Section I.1, the value of addiction 
research is intrinsically two-fold. Explicitly, it incrementally leads experimenters 




As well, though, to echo the point made in Section I.1, it implicitly informs 
ourselves about ourselves. As the architects of computers, human beings have 
the luxury of stacks upon stacks of circuit diagrams, manuals, and procedures 
that display in exquisite detail the mechanics and coding that make up electronic 
computing, from the higher-order graphical user interface down to the level of 
elementary voltage-dependent floating gates that comprise flash memory. By 
comparison, our collective understanding of the human brain is woefully 
incomplete, and is perhaps best exemplified by the persistent, and false, belief 
on the part of the general public that at any given time a person uses merely 10% 
of their brain – something one would do well not to attempt! While our 
understanding of the machinations of the mind pale in comparison, our approach 
to problem solving when an error is encountered follows a similar procedure, 
whether it be an organic or electronic “brain.”  
One first identifies at what level the error appears to originate. Alcohol 
intoxication is characterized by cognitive depression, leading to hypotheses that 
it inhibited excitatory neurotransmission that were ultimately confirmed. 
Researchers then focused their attention to the next level down, interrogating 
what molecular substrates elicited such depression of excitation. With the 
concerted efforts of an entire field, such a line of questioning not only parsed 
glutamatergic neurotransmission into three distinct receptor classes, identifying 




central importance of this receptor in the manifestation of learning and memory – 
a biological equivalent to the floating gates of flash memory. 
By this analogy, we begin appreciate the latent value of molecular 
biological research, and by understanding the low-level intra- and inter-molecular 
interactions that percolate up into higher order cognitive processes, a view to 
treatment becomes clearer. These islands of insight discovered a fortiori in the 
pursuit of elevating the health of humanity legitimize and reinforce the argument 
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